• 1  Stern S. Dermatologists and office‐based care of dermatologist disease in the 21st century. J Invest Dermatol Symp Proc 2004;9:12630.Cross Ref link
  • 2  Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol 2005;14:14352.Cross Ref linkPubmed link
  • 3  Perkins AC, Cheng CE, Hillebrand GG, et al. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol 2011;25:105460.Cross Ref linkPubmed link
  • 4  Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol 2005;14:14352.Cross Ref linkPubmed link
  • 5  Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol 2011;25:105460.Cross Ref linkPubmed link
  • 6  Thiboutot D, Gollnick H, Bettolli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne Group. J Am Acad Dermatol 2009;60(5 Suppl.):S150.Cross Ref linkPubmed link
  • 7  Layton AM, Henderson C, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 1994;19:3038.Cross Ref linkPubmed link
  • 8  Friedlander SF, Eichenfield LF, Fowler JF Jr, et al. Acne epidemiology and pathophysiology. Semin Cutan Med Surg 2010;29(2 Suppl. 1):24.Cross Ref linkPubmed link
  • 9  Goldberg JL, Dabade TS, Davis SA, et al. Changing age of acne vulgaris visits: another sign of earlier puberty? Pediatr Dermatol 2011;28:6458.Cross Ref linkPubmed link
  • 10  Kim GK, Michaels BB. Post‐adolescent acne in women: more common and more clinical considerations. J Drugs Dermatol 2012;11:70813.Pubmed link
  • 11  Biro FM, Greenspan LC, Galvez MP. Puberty in girls of the 21st century. J Pediatr Adolesc Gynaecol 2012;25:28994.Cross Ref link
  • 12  Lee Y, Styne D. Influences on the onset and tempo of puberty in human beings and implications for adolescent psychological development. Horm Behav 2013;64:25061.Cross Ref linkPubmed link
  • 13  Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol 1997;38:11523.Cross Ref linkPubmed link
  • 14  Wu TQ, Mei SQ, Zhang JX, et al. Prevalence and risk factors of facial acne vulgaris among Chinese adolescents. Int J Adolesc Med Health 2007;19:40712.Pubmed link
  • 15  Shen Y, Wang T, Zhou C, et al. Prevalence of acne vulgaris in Chinese adolescents and adults: a community‐based study of 17,345 subjects in six cities. Acta Derm Venereol 2012;92:404.Cross Ref linkPubmed link
  • 16  Lucky AW, Biro FM, Huster GA, et al. Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age. Arch Dermatol 1991;127:21016.Cross Ref linkPubmed link
  • 17  Lucky AW, Biro FM, Simbartl LA, et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five‐year longitudinal study. J Pediatr 1997;130:309.Cross Ref linkPubmed link
  • 18  Mourelatos K, Eady EA, Cunliffe WJ, et al. Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne. Br J Dermatol 2007;156:2231.Cross Ref linkPubmed link
  • 19  Ibanez L, Dimartino‐Nardi J, Potau N, et al. Premature adrenarche: normal variant or forerunner of adult disease? Endocr Rev 2000;21:67196.Pubmed link
  • 20  Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first‐degree relatives of affected and unaffected individuals. Br J Dermatol 1999;141:297300.Cross Ref linkPubmed link
  • 21  Khunger N, Kumar C. A clinico‐epidemiological study of adult acne: is it different from adolescent acne? Indian J Dermatol Venereol Leprol 2012;78:33541.Cross Ref linkPubmed link
  • 22  Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris in women: prevalence across the life span. J Womens Health (Larchmt) 2012;21:22330.Cross Ref linkPubmed link
  • 23  Silverberg JI, Silverberg NB. Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population‐based study. Br J Dermatol 2014;170:113642.Cross Ref linkPubmed link
  • 24  Rombouts S, Nijsten T, Lambert J. Cigarette smoking and acne in adolescents: results from a cross‐sectional study. J Eur Acad Dermatol Venereol 2007;21:32633.Cross Ref linkPubmed link
  • 25  Uslu G, Sendur N, Uslu M, et al. Acne: prevalence, perceptions and effects on psychological health among adolescents in Aydin, Turkey. J Eur Acad Dermatol Venereol 2008;22:4629.Cross Ref linkPubmed link
  • 26  Hanisah A, Omar K, Shah SA. Prevalence of acne and its impact on the quality of life in school‐aged adolescents in Malaysia. J Prim Health Care 2009;1:205.Pubmed link
  • 27  Muthupalaniappen L, Tan HC, Puah JW, et al. Acne prevalence, severity and risk factors among medical students in Malaysia. Clin Ter 2014;165:18792.Pubmed link
  • 28  Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 2014;134:152734.Cross Ref linkPubmed link
  • 29  Davis SA, Narahari S, Feldman SR, et al. Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol 2012;11:46673.Pubmed link
  • 30  Lolis MS, Bowe WP, Shalita AR. Acne and systemic disease. Med Clin North Am 2009;93:116181.Cross Ref linkPubmed link
  • 31  Chen W, Obermayer‐Pietsch B, Hong JB, et al. Acne‐associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol 2011;25:63746.Cross Ref linkPubmed link
  • 32  Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013;98:456592.Cross Ref linkPubmed link
  • 33  Wijeyaratne CN, Balen AH, Barth JH, et al. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol 2002;57:34350.Cross Ref link
  • 34  Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:45362.Cross Ref linkPubmed link
  • 35  Chang WY, Knochenhauer ES, Bartolucci AA, et al. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005;83:171723.Cross Ref linkPubmed link
  • 36  Hahn S, Bering van Halteren W, Roesler S, et al. The combination of increased ovarian volume and follicle number is associated with more severe hyperandrogenism in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006;114:17581.Cross Ref linkPubmed link
  • 37  Li L, Yang D, Chen X, et al. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet 2007;97:12934.Cross Ref linkPubmed link
  • 38  Liou TH, Yang JH, Hsieh CH, et al. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril 2009;92:19605.Cross Ref linkPubmed link
  • 39  Pembe AB, Abeid MS. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania. Tanzania J Health Res 2009;11:17580.
  • 40  Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol 2010;162:10939.Cross Ref linkPubmed link
  • 41  Bekx MT, Connor EC, Allen DB. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol 2010;23:710.Cross Ref linkPubmed link
  • 42  Bhattacharya SM, Ghosh M. Insulin resistance and adolescent girls with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2010;23:15861.Cross Ref linkPubmed link
  • 43  Bhattacharya SM, Ghosh M, Nandi N. Effects of drospirenone pill in Indian women with polycystic ovary syndrome. J Turk Ger Gynecol Assoc 2011;12:1447.Cross Ref linkPubmed link
  • 44  Bhattacharya SM, Ghosh M, Basu R. Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome. J Obstet Gynaecol Res 2012;38:28590.Cross Ref linkPubmed link
  • 45  Siddiqui IA, Tamimi W, Tamim H, et al. A study on clinical and sonographic features in obese and nonobese patients with polycystic ovary syndrome. Arch Gynecol Obstet 2010;281:46771.Cross Ref linkPubmed link
  • 46  Ozdemir S, Ozdemir M, Gorkemli H, et al. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Acta Obstet Gynecol Scand 2010;89:199204.Cross Ref linkPubmed link
  • 47  Asgharnia M, Mirblook F, Ahmad Soltani M. The Prevalence of Polycystic Ovary Syndrome (PCOS) in High School Students in Rasht in 2009 According to NIH Criteria. Int J Fertil Steril 2011;4:1569.Pubmed link
  • 48  Bronstein J, Tawdekar S, Liu Y, et al. Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought. J Pediatr Adolesc Gynecol 2011;24:1520.Cross Ref linkPubmed link
  • 49  Chen MJ, Chen CD, Yang JH, et al. High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome. Hum Reprod 2011;26:22734.Cross Ref linkPubmed link
  • 50  Skampardonis N, Kouskoukis A, Karpouzis A, et al. Marked hyperandrogenemia and acne associated with polycystic ovaries in Greek women with polycystic ovary syndrome. Clin Exp Obstet Gynecol 2011;38:16871.Pubmed link
  • 51  Baldani DP, Skrgatic L, Goldstajn MS, et al. Clinical and biochemical characteristics of polycystic ovary syndrome in Croatian population. Coll Antropol 2012;36:141318.Pubmed link
  • 52  Nair MK, Pappachan P, Balakrishnan S, et al. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls – a 2 year follow‐up study. Indian J Pediatr 2012;79 Suppl. 1:S6973.Cross Ref linkPubmed link
  • 53  Saxena P, Prakash A, Nigam A, et al. Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Indian J Endocrinol Metabol 2012;16:9969.Cross Ref link
  • 54  Hacivelioglu S, Gungor AN, Gencer M, et al. Acne severity and the Global Acne Grading System in polycystic ovary syndrome. Int J Gynaecol Obstet 2013;123:336.Cross Ref linkPubmed link
  • 55  McManus SS, Levitsky LL, Misra M. Polycystic ovary syndrome: clinical presentation in normal‐weight compared with overweight adolescents. Endocr Pract 2013;19:4718.Cross Ref linkPubmed link
  • 56  Musmar S, Afaneh A, Mo'alla H. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An‐Najah national university‐Palestine. Reprod Biol Endocrinol 2013;11:47.Cross Ref linkPubmed link
  • 57  Wang ET, Kao CN, Shinkai K, et al. Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross‐sectional study. Fertil Steril 2013;100:21418.Cross Ref linkPubmed link
  • 58  Hong JS, Kwon HH, Park SY, et al. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients. J Eur Acad Dermatol Venereol 2014: Mar 14 epub.Pubmed link
  • 59  Quinn M, Shinkai K, Pasch L, et al. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertil Steril 2014;101:112934.Cross Ref linkPubmed link
  • 60  Tuten A, Sahmay S, Oncul M, et al. Serum AMH levels in the differential diagnosis of hyperandrogenemic conditions. Eur J Obstet Gynecol Reprod Biol 2014;177:1215.Cross Ref linkPubmed link
  • 61  Williamson K, Gunn AJ, Johnson N, et al. The impact of ethnicity on the presentation of polycystic ovarian syndrome. Aust NZ J Obstet Gynaecol 2001;41:2026.Cross Ref link
  • 62  Christensen SB, Black MH, Smith N, et al. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril 2013;100:4707.Cross Ref linkPubmed link
  • 63  Anderson AD, Solorzano CM, McCartney CR. Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med 2014;32:20213.Cross Ref linkPubmed link
  • 64  Williams RM, Ong KK, Dunger DB. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol 2013;373:617.Cross Ref linkPubmed link
  • 65  Vilmann LS, Thisted E, Baker JL, et al. Development of obesity and polycystic ovary syndrome in adolescents. Horm Res Paediatr 2012;78:26978.Cross Ref linkPubmed link
  • 66  Diamanti‐Kandarakis E. PCOS in adolescents. Best Pract Res Clin Obstet Gynaecol 2010;24:17383.Cross Ref linkPubmed link
  • 67  Musmar S, Afaneh A, Mo'alla H. Epidemiology of polycystic ovary syndrome: a cross sectional study of university students at An‐Najah National University, Palestine. Reprod Biol Endocrinol 2013;11:47.Cross Ref linkPubmed link
  • 68  Nair MK, Pappachan P, Balakrishnan S, et al. Menstrual irregularity and polycystic ovarian syndrome among adolescent girls: a 2 year follow‐up study. Indian J Pediatr 2012;79(Suppl. 1):S6973.Cross Ref linkPubmed link
  • 69  Esmaeilzadeh S, Delavar MA, Amiri M, et al. Polycystic ovary syndrome in Iranian adolescents. Int J Adolesc Med Health 2014;26:55965.Cross Ref linkPubmed link
  • 70  Bunker CB, Newton JA, Kilborn J, et al. Most women with acne have polycystic ovaries. Br J Dermatol 1989;121:67580.Cross Ref linkPubmed link
  • 71  Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol 2010;9:1428.Cross Ref linkPubmed link
  • 72  Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010:625105 doi: 10.1155/2010/625105.Cross Ref linkPubmed link
  • 73  Honour JW. 17‐Hydroxyprogesterone in children, adolescents and adults. Ann Clin Biochem 2014;51:42440.Cross Ref linkPubmed link
  • 74  Ostlere LS, Rumsby G, Holownia P, et al. Carrier status for steroid 21‐hydroxylase deficiency is only one factor in the variable phenotype of acne. Endocrinology 1998;48:20915.
  • 75  Marynick S Chakmakjian Z, McCaffree D, et al. Androgen excess in cystic acne. N Engl J Med 1983;308:9816.Cross Ref linkPubmed link
  • 76  Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005;365:212536.Cross Ref linkPubmed link
  • 77  New MI. Extensive clinical experience: non classical 21‐hydroxylase deficiency. J Clin Endocrinol Metab 2006;91:420514.Cross Ref linkPubmed link
  • 78  Degitz K, Plackzek M, Arnold B, et al. Congenital adrenal hyperplasia and acne in male patients. Br J Dermatol 2003;148:12636.Cross Ref linkPubmed link
  • 79  Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 2004;22:41928.Cross Ref linkPubmed link
  • 80  Chalmers RJ, Ead RD, Beck MH, Dewis P, Anderson DC. Acne vulgaris and hidradenitis suppurativa are presenting features of acromegaly. BMJ (Clin Res Ed) 1983;287:13467.Cross Ref link
  • 81  Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000;21:36392.Cross Ref linkPubmed link
  • 82  Deplewski D, Rosenfield RL. Growth hormone and insulin‐like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999;149:408994.
  • 83  Rizvi AA. Some clues and pitfalls in the diagnosis of acromegaly. Endocr Pract 2004;10:34852.Cross Ref linkPubmed link
  • 84  Beretta‐Piccoli BC, Sauvain MHJ, Gal I, et al. Synovitis, acne pustulosis, hyperostosis osteitis (SAPHO) syndrome in childhood: a report of 10 cases and review of the literature. Eur J Pediatr 2000;159:594601.Cross Ref linkPubmed link
  • 85  Van Doorman S, Barraclough D, McColl G, et al. SAPHO: rare or just not recognised? Semin Arthritis Rheum 2000;93:707.Cross Ref link
  • 86  Colina M, Lo Monaro A, Khodien M. Propionibacterium acnes and SAPHO: a case report and a literature review. Clin Exp Rheumatol 2007;25:45760.Pubmed link
  • 87  Olivieri I, Padula A, Palazzi C. Pharmacological management of SAPHO syndrome. Exp Opin Invest Drugs 2006;15:122933.Cross Ref link
  • 88  Delattre E, Guillot X, Godfrin‐Valnet M, et al. SAPHO syndrome treatment with intravenous pamidronate: retrospective study of 22 patients. Joint Bone Spine 2014;81:4568.Cross Ref linkPubmed link
  • 89  Iqbal M, Kolodney MS. Acne fulminans and synovitis‐acne‐pustulosis‐hyperostosis‐osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol 2005;52(5 Suppl. 1):S11820.Cross Ref linkPubmed link
  • 90  Firinu D, Murgia G, Lorrai MM, et al. Biological treatments for SAPHO syndrome: an update. Inflamm Allergy Drug Targets 2014;13:199205.Cross Ref linkPubmed link
  • 91  Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti‐TNF‐alpha therapy may induce persistent amelioration of osteoarticular complaints, but exacerbate cutaneous manifestations. Rheumatology 2006;45:7303.Cross Ref linkPubmed link
  • 92  Rager KM, Omar HA. Androgen excess disorders in women: the severe insulin‐resistant hyperandrogen syndrome, HAIR‐AN. Sci World J 2006;6:11621.Cross Ref link
  • 93  Elmer KB, George RM. HAIR‐AN syndrome: a multisystem challenge. Am Fam Physician 2001;63:238590.Pubmed link
  • 94  Shen Z, Hao F, Wei P. HAIR‐AN syndrome in a male adolescent with concomitant vitiligo. Arch Dermatol 2009;145:4924.Cross Ref linkPubmed link
  • 95  Ingletto D, Ruggiero L, De Sanctis V. HAIR‐AN syndrome (hyperandrogenism, insulin resistance, acanthosis nigricans) in an adolescent with Cohen's syndrome. Minerva Pediatr 2001;53:4934.Pubmed link
  • 96  Somani N, Harrison S, Bergfeld WF. The clinical evaluation of hirsutism. Dermatol Ther 2008;21:37691.Cross Ref linkPubmed link
  • 97  Musso C, Cochran E, Moran SA, et al. Clinical course of genetic diseases of insulin receptor (type A and Rabson–Mendehall syndromes): a 30‐year prospective. Medicine (Baltimore) 2004;83:20922.Cross Ref linkPubmed link
  • 98  Makrantonaki E, Vogel K, Fimmel S, et al. Interplay of IGF‐1 and 17beta‐estradiol at age‐specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol 2008;43:93946.Cross Ref linkPubmed link
  • 99  Orfanos CE. Antiandrogenos en dermatologia. Arch Arg Derm 1982;32(Suppl. 1):515.
  • 100  Orfanos CE, Adler YA, Zouboulis CC. The SAHA syndrome. Horm Res 2000;54:2518.Cross Ref linkPubmed link
  • 101  Yang H, Reinherz E. CD2BP1 modulates CD2‐dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)‐PEST. J Immunol 2006;176:5898907.Cross Ref linkPubmed link
  • 102  Shoham NG, Centola M, Mansfield E, et al. Pyrin binds the PSTPIP/CD2BP1 protein, defining Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 2003;100:135016.Cross Ref linkPubmed link
  • 103  Lindor NM, Arsenault TM, Solomon H, et al. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum and acne: PAPA syndrome. Rheumatology (Oxford) 2005;44:4068.
  • 104  Demodowich AP, Freeman AF, Kuhns DB, et al. Genotype, phenotype and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gandrenosum, and acne). Arthritis Rheum 2012;64:20227.Cross Ref linkPubmed link
  • 105  Apert E. De l'a acroencephalosyndactylie. Bull Soc Med Hop (Paris) 1906;23:131030.
  • 106  Boulet SL, Rasmussen SA, Honein MA. A population‐based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A 2008;146:98491.Cross Ref link
  • 107  Kreiborg S, Cohen MM Jr. The oral manifestations of Apert's syndrome. J Cranofac Genet Dev Biol 1992;12:418.
  • 108  Freiman A, Tessler O, Barankin B. Apert syndrome. Int J Dermatol 2006;45:13413.Cross Ref linkPubmed link
  • 109  Atherton DJ, Rebella T. Apert's syndrome with severe acne vulgaris. Proc R Soc Med 1976;69:51718.Pubmed link
  • 110  Cohn MS, Mahon MJ. Apert's syndrome in a patient with hyperhidrosis. Cutis 1993;52:2058.Pubmed link
  • 111  Solomon LM, Fretzin D, Pruzansky S. Pilosebaceous abnormalities in Apert's syndrome. Arch Dermatol 1970;102:3815.Cross Ref linkPubmed link
  • 112  Henderson CA, Knaggs H, Clark A, et al. Apert's syndrome and androgen receptor staining of the basal cells of sebaceous glands. Br J Dermatol 1995;132:13943.Cross Ref linkPubmed link
  • 113  Campanati A, Marconi B, Penna L, et al. Pronounced and early acne in Apert's syndrome: a case successfully treated with oral isotretinoin. Eur J Dermatol 2002;12:4968.Pubmed link
  • 114  Gilaberte M, Puig L, Alomar A. Isotretinoin treatment of acne in a patient with Apert's syndrome. Pediatr Dermatol 2003;20:4436.Cross Ref linkPubmed link
  • 115  Cohen MM, Kreiborg S. Cutaneous manifestations of Apert's syndrome. Am J Med Genet 1995;58:946.Cross Ref linkPubmed link
  • 116  Melnik BC. Role of FGFR2 signaling in the pathogenesis of acne. Dermatoendocrinology 2009;1:14156.Cross Ref link
  • 117  Downs AMR, Condon CA, Tan R. Isotretinoin therapy for antibiotic‐refractory acne in Apert's syndrome. Clin Exp Dermatol 1999;24:4613.Cross Ref linkPubmed link
  • 118  Cuerda E, Del Pozo J, Rodriguez‐Lozano J, et al. Acne in Apert's syndrome: treatment with isotretinoin. J Dermatol Treat 2003;14:435.Cross Ref link
  • 119  Steffen C. The acneiform eruption of Apert's syndrome is not acne vulgaris. Am J Dermatopathol 1984;6:21320.Cross Ref linkPubmed link
  • 120  Momin SB, Peterson A, Del Rosso JQ. A status report on drug‐associated acne and acneiform eruptions. J Drugs Dermatol 2010;9:62736.Pubmed link
  • 121  Du‐Thanh A, Kluger N, Bensalleh H, et al. Drug‐induced acneiform eruption. Am J Clin Dermatol 2011;12:23345.Cross Ref linkPubmed link
  • 122  Dessinioti C, Antoniou C, Katsambas A. Acneiform eruptions. Clin Dermatol 2014;32:2434.Cross Ref linkPubmed link
  • 123  Plewig G, Kligman AM. Induction of acne by topical steroids. Arch Dermatol Forsch 1973;247:2952.Cross Ref linkPubmed link
  • 124  Monk B, Cunliffe WJ, Layton AM, Rhodes DJ. Acne induced by inhaled corticosteroids. Clin Exp Dermatol 1993;18:14850.Cross Ref linkPubmed link
  • 125  Daltrey DC, Cunliffe WJ. Effect of betamethasone valerate on the normal facial skin flora. Acta Derm Venereol (Stockh) 1983;63:1602.
  • 126  Bong JL, Connell JM, Lever R. Intranasal betamethasone induced acne and adrenal suppression. Br J Dermatol 2000;142:57980.Cross Ref linkPubmed link
  • 127  Fung MA, Berger TG. A prospective study of acute‐onset steroid acne associated with administration of intravenous corticosteroids. Dermatology 2000;200:434.Cross Ref linkPubmed link
  • 128  Guillot B. Adverse skin reactions to inhaled steroids. Expert Opin Drug Saf 2002;1:3259.Cross Ref linkPubmed link
  • 129  Plewig G, Strzeminski YA. Iodide and skin disease. Dtsch Med Wochenschr 1985;110:12669.Pubmed link
  • 130  Razavi Z, Moeini B, Shafiei Y, et al. Prevalence of anabolic steroid use and associated factors among body‐builders in Hamadan, West Province of Iran. J Res Health Sci 2014;14:1636.Pubmed link
  • 131  Kiraly CL, Alen M, Korvola J, et al. The effect of testosterone and anabolic steroids on the skin surface lipids and the population of Propionibacterium acnes in young post‐pubertal men. Acta Derm Venereol 1988;68:216.Pubmed link
  • 132  Scott MJ, Scott AM. Effects of anabolic‐androgenic steroids on the pilosebaceous unit. Cutis 1992;50:11316.Pubmed link
  • 133  O'Sullivan AJ, Kennedy MC, Casey JH, et al. Anabolic‐androgenic steroids: medical assessment of present, past and potential users. Med J Aust 2000;173:3237.Pubmed link
  • 134  Mahé E, Morelon E, Lechaton S, et al. Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic and pathogenic aspects. J Am Acad Dermatol 2006;55:13942.Cross Ref linkPubmed link
  • 135  Kunzle N, Vebetz JP, Pascual M, et al. Sirolimus‐induced acneifom eruption. Dermatology 2005;211:3669.Cross Ref linkPubmed link
  • 136  Moloney FJ, Kene S, O'Kelly P, et al. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol 2005;153:5748.Cross Ref linkPubmed link
  • 137  Bakos L, Marchiori BR. Focal acne during topical tacrolimus therapy for vitiligo. Arch Dermatol 2007;143:12234.Pubmed link
  • 138  Oztas P, Aksakal AB, Oztas MO, et al. Severe acne with lithium. Ann Pharmacother 2001;35:9612.Cross Ref linkPubmed link
  • 139  Scarfi F, Arunachalam M. Lithium acne. Can Med Assoc J 2013;185:1525.Cross Ref link
  • 140  Vexiau P, Husson C, Chivot M, et al. Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J Invest Dermatol 1990;94:27983.Cross Ref linkPubmed link
  • 141  Bettoli V, Trimurti S, Lombardi AR, et al. Acne due to amineptine abuse. J Eur Acad Dermatol Venereol 1998;10:2813.Cross Ref linkPubmed link
  • 142  Aithal V, Appaih P. Lithium induced hidradenitis suppurativa and acne conglobata. Indian J Dermatol Venereol Leprol 2004;70:3079.Pubmed link
  • 143  Yeung CK, Chan HH, Cutaneous adverse effects of lithium: epidemiology and management. Am J Dermatol 2004;5:38.Cross Ref link
  • 144  Cohen EB, Rossen NN. Acne vulgaris in connection with the use of progestogens in a hormonal IUD or a subcutaneous implant. Ned Tijdschr Geneeskd 2003;147:21379.Pubmed link
  • 145  Cohen LK, George W, Smith R. Isoniazid‐induced acne and pellagra: occurrence in slow inactivators of isoniazid. Arch Dermatol 1974;109:37781.Cross Ref linkPubmed link
  • 146  Greenwood R, Fenwick PB, Cunliffe WJ. Acne and anti‐convulsants. BMJ 1983;287:166970.Cross Ref linkPubmed link
  • 147  Papa CM. Acne and hidden iodides [Letter]. Arch Dermatol 1976;112:5556.Cross Ref linkPubmed link
  • 148  Dupre A, Alberel N, Bonafe JL, et al. Vitamin B‐12 induced acnes. Cutis 1979;24:21011.Pubmed link
  • 149  Kang D, Baochen Shi, Erfe MC, et al. Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis. Sci Transl Med 2015;7(293):293ra103.Cross Ref linkPubmed link
  • 150  Busam KJ, Capodiece P, Motzer R, et al. Cutaneous side‐effects in cancer patients treated with the anti epidermal growth factor receptor antibody C 225. Br J Dermatol 2001;144:116976.Cross Ref linkPubmed link
  • 151  Segaert S, Tabernero J, Chosidow O, et al. The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies. J Dtsch Dermatol Ges 2005;3:599606.Cross Ref linkPubmed link
  • 152  Molinari E, De Quatrebarbes J, Anbdre T, et al. Cetuximab induced acne. Dermatology 2005;211:3303.Cross Ref linkPubmed link
  • 153  Gutzmer R, Werfel T, Mao R, et al. Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy. Br J Dermatol 2005;153:84951.Cross Ref linkPubmed link
  • 154  Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol 2013;168:47485.Cross Ref linkPubmed link
  • 155  Xu SX, Wang HL, Fan X, et al. The familial risk of acne vulgaris in Chinese Hans: a case‐control study. J Eur Acad Dermatol Venereol 2007;21:6025.Pubmed link
  • 156  Wei B, Pang Y, Zhu H, et al. The epidemiology of adolescent acne in North East China. J Eur Acad Dermatol Venereol 2010;24:9537.Cross Ref linkPubmed link
  • 157  Di Landro A, Cazzaniga S, Parazzini F, et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012;67:112935.Cross Ref linkPubmed link
  • 158  Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first‐degree relatives of affected and unaffected individuals. Br J Dermatol 1999;141:297300.Cross Ref linkPubmed link
  • 159  Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community‐based study. J Invest Dermatol 2009;129:213641.Cross Ref linkPubmed link
  • 160  Ismail NH, Manaf ZA, Azizan NZ. High glycemic load diet, milk and ice cream consumption are related to acne vulgaris in Malaysian young adults: a case control study. BMC Dermatol 2012;12:13.Cross Ref linkPubmed link
  • 161  Karciauskiene J, Valiukeviciene S, Gollnick H, et al. The prevalence and risk factors of adolescent acne among schoolchildren in Lithuania: a cross‐sectional study. J Eur Acad Dermatol Venereol 2014;28:73340.Cross Ref linkPubmed link
  • 162  Suh DH, Kim BY, Min SU, et al. A multicenter epidemiological study of acne vulgaris in Korea. Int J Dermatol 2011;50:67381.Cross Ref linkPubmed link
  • 163  Cho EB, Ha JM, Park EJ, et al. Heredity of acne in Korean patients. J Dermatol 2014;41:91517.Cross Ref linkPubmed link
  • 164  Ballanger F, Baudry P, N'Guyen JM, et al. Heredity: a prognostic factor for acne. Dermatology 2006;212:1459.Cross Ref linkPubmed link
  • 165  Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion and acne: a twin study. Br J Dermatol 1988;118:3936.Cross Ref linkPubmed link
  • 166  Navarini AA, Simpson MA, Weale M, et al. Genome‐wide association study identifies three novel loci for severe acne vulgaris. Nat Commun 2014;5:4020.Cross Ref linkPubmed link
  • 167  Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002;138:158490.Cross Ref linkPubmed link
  • 168  Schaefer O. When the Eskimo comes to town. Nutr Today 1971;6:816.Cross Ref link
  • 169  Tan HH, Tan AW, Barkham T, et al. Community‐based study of acne vulgaris in adolescents in Singapore. Br J Dermatol 2007;157:54751.Cross Ref linkPubmed link
  • 170  Rigopoulos D, Gregoriou S, Ifandi A, et al. Coping with acne: beliefs and perceptions in a sample of secondary school Greek pupils. J Eur Acad Dermatol Venereol 2007;21:80610.Cross Ref linkPubmed link
  • 171  Yahya H. Acne vulgaris in Nigerian adolescents: prevalence, severity, beliefs, perceptions, and practices. Int J Dermatol 2009;48:498505.Cross Ref linkPubmed link
  • 172  Jung JY, Yoon MY, Min SU, et al. The influence of dietary patterns on acne vulgaris in Koreans. Eur J Dermatol 2010;20:76872.Pubmed link
  • 173  El‐Akawi Z, Abdel‐Latif Nemr N, Abdul‐Razzak K, et al. Factors believed by Jordanian acne patients to affect their acne condition. Eastern Med Health J 2006;12:8406.
  • 174  Poli F, Auffret N, Beylot C, et al. Acne as seen by adolescents: results of questionnaire study in 852 French individuals. Acta Derm Venereol 2011;91:5316.Cross Ref linkPubmed link
  • 175  Burris J, Rietkerk W, Woolf K. Relationships of self‐reported dietary factors and perceived acne severity in a cohort of New York young adults. J Acad Nutr Diet 2014;114:38492.Cross Ref linkPubmed link
  • 176  Aksu AE, Metintas S, Saracoglu ZN, et al. Acne: prevalence and relationship with dietary habits in Eskisehir, Turkey. J Eur Acad Dermatol Venereol 2012;26:15039.Pubmed link
  • 177  Veith WB, Silverberg NB. The association of acne vulgaris with diet. Cutis 2011;88:8491.Pubmed link
  • 178  Smith RN, Mann NJ, Braue A, et al. The effect of a high‐protein, low glycemic‐load diet versus a conventional, high glycemic‐load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator‐masked, controlled trial. J Am Acad Dermatol 2007;57:24756.Cross Ref linkPubmed link
  • 179  Smith RN, Braue A, Varigos GA, et al. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci 2008;50:4152.Cross Ref linkPubmed link
  • 180  Kaymak Y, Adisen E, Ilter N, et al. Dietary glycemic index and glucose, insulin, insulin‐like growth factor‐I, insulin‐like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 2007;57:81923.Cross Ref linkPubmed link
  • 181  Smith R, Mann N, Makelainen H, et al. A pilot study to determine the short‐term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res 2008;52:71826.Cross Ref linkPubmed link
  • 182  Adebamowo CA, Spiegelman D, Danby FW, et al. High school dietary dairy intake and teenage acne. J Am Acad Dermatol 2005;52:20714.Cross Ref linkPubmed link
  • 183  Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in adolescent girls. Dermatol Online J 2006;12:1.Pubmed link
  • 184  Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008;58:78793.Cross Ref linkPubmed link
  • 185  Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community‐based study. J Invest Dermatol 2009;129:213641.Cross Ref linkPubmed link
  • 186  Halvorsen JA, Dalgard F, Thoresen M, et al. Is the association between acne and mental distress influenced by diet? Results from a cross‐sectional population study among 3775 late adolescents in Oslo, Norway. BMC Public Health 2009;9:340.Cross Ref linkPubmed link
  • 187  Jung JY, Yoon MY, Min SU, et al. The influence of dietary patterns on acne vulgaris in Koreans. Eur J Dermatol 2010;20:76872.Pubmed link
  • 188  Reynolds RC, Lee S, Choi JY, et al. Effect of the glycemic index of carbohydrates on Acne vulgaris. Nutrients 2010;2:106072.Cross Ref linkPubmed link
  • 189  Di Landro A, Cazzaniga S, Parazzini F, et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012;67:112935.Cross Ref linkPubmed link
  • 190  Ismail NH, Manaf ZA, Azizan NZ. High glycemic load diet, milk and ice cream consumption are related to acne vulgaris in Malaysian young adults: a case control study. BMC Dermatol 2012;12:13.Cross Ref linkPubmed link
  • 191  Kwon HH, Yoon JY, Hong JS, et al. Clinical and histological effect of a low glycaemic load diet in treatment of acne vulgaris in Korean patients: a randomized, controlled trial. Acta Derm Venereol 2012;92:2416.Cross Ref linkPubmed link
  • 192  Skroza N, Tolino E, Semyonov L, et al. Mediterranean diet and familial dysmetabolism as factors influencing the development of acne. Scand J Public Health 2012;40:46674.Cross Ref linkPubmed link
  • 193  Burris J, Rietkerk W, Woolf K. Relationships of self‐reported dietary factors and perceived acne severity in a cohort of New York young adults. J Acad Nutr Dietet 2014;114:38492.Cross Ref link
  • 194  Block SG, Valins WE, Caperton CV, et al. Exacerbation of facial acne vulgaris after consuming pure chocolate. J Am Acad Dermatol 2011;65:e11415.Cross Ref linkPubmed link
  • 195  Caperton C, Block S, Viera M, et al. Double‐blind, placebo‐controlled study assessing the effect of chocolate consumption in subjects with a history of acne vulgaris. J Clin Aesthet Dermatol 2014;7:1923.Pubmed link
  • 196  Smith RN, Mann NJ, Braue A, et al. The effect of a high‐protein, low glycemic‐load diet versus a conventional, high glycemic‐load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator‐masked, controlled trial. J Am Acad Dermatol 2007;57:24756.Cross Ref linkPubmed link
  • 197  Kwon HH, Yoon JY, Hong JS, et al. Clinical and histological effect of a low glycaemic load diet in treatment of acne vulgaris in Korean patients: a randomized, controlled trial. Acta Derm Venereol 2012;92:2416.Cross Ref linkPubmed link
  • 198  Kaymak Y, Adisen E, Ilter N, et al. Dietary glycemic index and glucose, insulin, insulin‐like growth factor‐I, insulin‐like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 2007;57:81923.Cross Ref linkPubmed link
  • 199  Reynolds RC, Lee S, Choi JY, et al. Effect of the glycemic index of carbohydrates on acne vulgaris. Nutrients 2010;2:106072.Cross Ref linkPubmed link
  • 200  Smith R, Mann N, Makelainen H, et al. A pilot study to determine the short‐term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res 2008;52:71826.Cross Ref linkPubmed link
  • 201  Bowe W, Patel NB, Logan AC. Acne vulgaris, probiotics and the gut–brain–skin axis: from anecdote to translational medicine. Benef Microbes 2014;5:18599.Cross Ref linkPubmed link
  • 202  Melnik B. Dietary intervention in acne: attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinology 2012;4:2032.Cross Ref link
  • 203  Khayef G, Young J, Burns‐Whitmore B, et al. Effects of fish oil supplementation on inflammatory acne. Lipids Health Dis 2012;11:165.Cross Ref linkPubmed link
  • 204  Skroza N, Tolino E, Semyonov L, et al. Mediterranean diet and familial dysmetabolism as factors influencing the development of acne. Scand J Public Health 2012;40:46674.Cross Ref linkPubmed link
  • 205  Muizzuddin N, Maher W, Sullivan M, et al. Physiological effect of a probiotic on skin. J Cosmetic Sci 2012;63:38595.
  • 206  Roudsari MR, Karimi R, Mortazavian AM. Health effects of probiotics on the skin. Crit Rev Food Sci Nutr 2015;55:121940.Cross Ref linkPubmed link
  • 207  Baquerizo Nole KL, Yim E, Keri JE. Probiotics and prebiotics in dermatology. J Am Acad Dermatol 2014;71:81421.Cross Ref linkPubmed link
  • 208  Jung JY, Kwon HH, Hong JS, et al. Effect of dietary supplementation with omega‐3 fatty acid and gamma‐linolenic acid on acne vulgaris: a randomised, double‐blind, controlled trial. Acta Derm Venereol 2014;94:5215.Cross Ref linkPubmed link
  • 209  Di Landro A, Cazzaniga S, Parazzini F, et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012;67:112935.Cross Ref linkPubmed link
  • 210  Tsai MC, Chen W, Cheng YW, et al. Higher body mass index is a significant risk factor for acne formation in schoolchildren. Eur J Dermatol 2006;16:2513.Pubmed link
  • 211  Hogewoning AA, Koelemij I, Amoah AS, et al. Prevalence and risk factors of inflammatory acne vulgaris in rural and urban Ghanaian schoolchildren. Br J Dermatol 2009;161:4757.Cross Ref linkPubmed link
  • 212  Karciauskiene J, Valiukeviciene S, Gollnick H, et al. The prevalence and risk factors of adolescent acne among schoolchildren in Lithuania: a cross‐sectional study. J Eur Acad Dermatol Venereol 2014;28:73340.Cross Ref linkPubmed link
  • 213  Halvorsen JA, Vleugels RA, Bjertness E, et al. A population‐based study of acne and body mass index in adolescents. Arch Dermatol 2012;148:1312.Cross Ref linkPubmed link
  • 214  Del Prete M, Mauriello MC, Faggiano A, et al. Insulin resistance and acne: a new risk factor for men? Endocrine 2012;42:55560.Cross Ref linkPubmed link
  • 215  Ismail NH, Manaf ZA, Azizan NZ. High glycemic load diet, milk and ice cream consumption are related to acne vulgaris in Malaysian young adults: a case control study. BMC Dermatol 2012;12:13.Cross Ref linkPubmed link
  • 216  Alan S, Cenesizoglu E. Effects of hyperandrogenism and high body mass index on acne severity in women. Saudi Med J 2014;35:8869.Pubmed link
  • 217  Yang JH, Weng SL, Lee CY, et al. A comparative study of cutaneous manifestations of hyperandrogenism in obese and non‐obese Taiwanese women. Arch Gynecol Obstet 2010;282:32733.Cross Ref linkPubmed link
  • 218  Liou TH, Yang JH, Hsieh CH, et al. Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril 2009;92:19605.Cross Ref linkPubmed link
  • 219  Chen MJ, Chen CD, Yang JH, et al. High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome. Hum Reprod 2011;26:22734.Cross Ref linkPubmed link
  • 220  Baldani DP, Skrgatic L, Goldstajn MS, et al. Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and non‐obese women in the Croatian population. Coll Antropol 2013;37:46570.Pubmed link
  • 221  Hacivelioglu S, Gungor AN, Gencer M, et al. Acne severity and the Global Acne Grading System in polycystic ovary syndrome. Int J Gynaecol Obstet 2013;123:336.Cross Ref linkPubmed link
  • 222  Tamimi W, Siddiqui IA, Tamim H, et al. Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome. Int J Gynaecol Obstet 2009;107:547.Cross Ref linkPubmed link
  • 223  Ibricevic D, Asimi ZV. Frequency of prediabetes in women with polycystic ovary syndrome. Med Arch 2013;67:2825.Cross Ref linkPubmed link
  • 224  McManus SS, Levitsky LL, Misra M. Polycystic ovary syndrome: clinical presentation in normal‐weight compared with overweight adolescents. Endocr Pract 2013;19:4718.Cross Ref linkPubmed link
  • 225  Saxena P, Prakash A, Nigam A, et al. Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index. Indian J Endocrinol Metabol 2012;16:9969.Cross Ref link
  • 226  Shabir I, Ganie MA, Praveen EP, et al. Morning plasma cortisol is low among obese women with polycystic ovary syndrome. Gynecol Endocrinol 2013;29:10457.Cross Ref linkPubmed link
  • 227  Kurzen H, Wessler I, Kirkpatrick CJ, et al. The non‐neuronal cholinergic system of human skin. Horm Metab Res 2007;39:12535.Cross Ref linkPubmed link
  • 228  Hakonsen LB, Olsen J, Stovring H, et al. Maternal cigarette smoking during pregnancy and pubertal development in sons. A follow‐up study of a birth cohort. Andrology 2013;1:34855.Cross Ref linkPubmed link
  • 229  Galobardes B, Davey Smith G, Jeffreys M, et al. Acne in adolescence and cause‐specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study. Am J Epidemiol 2005;161:1094101.Cross Ref linkPubmed link
  • 230  Frisch RE. Weight at menarche: similarity for well‐nourished and under‐nourished girls at differing ages, and evidence for histologic constancy. Pediatrics 1972;50:44550.Pubmed link
  • 231  Lucky AW. Quantitative documentation of a premenstrual flare of facial acne in adult women. Arch Dermatol 2004;140:4234.Cross Ref linkPubmed link
  • 232  Fisher DA. Desideratum dermatologicum–cause and control of premenstrual acne flare. Int J Dermatol 2000;39:3346.Cross Ref linkPubmed link
  • 233  Stoll S, Shalita AR, Webster GF, et al. The effect of the menstrual cycle on acne. J Am Acad Dermatol 2001;45:95760.Cross Ref linkPubmed link
  • 234  Poli F, Auffret N, Beylot C, et al. Acne as seen by adolescents: results of questionnaire study in 852 French individuals. Acta Derm Venereol 2011;91:5316.Cross Ref linkPubmed link
  • 235  Al‐Ameer AM, Al‐Akloby OM. Demographic features and seasonal variations in patients with acne vulgaris in Saudi Arabia: a hospital‐based study. Int J Dermatol 2002;41:8701.Cross Ref linkPubmed link
  • 236  El‐Akawi Z, Abdel‐Latif Nemr N, Abdul‐Razzak K, et al. Factors believed by Jordanian acne patients to affect their acne condition. Eastern Med Health J 2006;12:8406.
  • 237  Adityan B, Thappa DM. Profile of acne vulgaris – a hospital‐based study from South India. Indian J Dermatol Venereol Leprol 2009;75:2728.Cross Ref linkPubmed link
  • 238  Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community‐based study. J Invest Dermatol 2009;129:213641.Cross Ref linkPubmed link
  • 239  Jung JY, Yoon MY, Min SU, et al. The influence of dietary patterns on acne vulgaris in Koreans. Eur J Dermatol 2010;20:76872.Pubmed link
  • 240  Poli F, Auffret N, Beylot C, et al. Acne as seen by adolescents: results of questionnaire study in 852 French individuals. Acta Derm Venereol 2011;91:5316.Cross Ref linkPubmed link
  • 241  Suh DH, Kim BY, Min SU, et al. A multicenter epidemiological study of acne vulgaris in Korea. Int J Dermatol 2011;50:67381.Cross Ref linkPubmed link
  • 242  Khunger N, Kumar C. A clinico‐epidemiological study of adult acne: is it different from adolescent acne? Indian J Dermatol Venereol Leprol 2012;78:33541.Cross Ref linkPubmed link
  • 243  Suthipinittharm P, Noppakun N, Kulthanan K, et al. Opinions and perceptions on acne: a community‐based questionnaire study in Thai students. J Med Assoc Thai 2013;96:9529.Pubmed link
  • 244  Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 2003;139:897900.Cross Ref linkPubmed link
  • 245  Yosipovitch G, Tang M, Dawn AG, et al. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol 2007;87:1359.Cross Ref linkPubmed link
  • 246  Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001;15:5415.Cross Ref linkPubmed link
  • 247  Corey KC, Cheng CE, Irwin B, et al. Self‐reported help‐seeking behaviors and treatment choices of adolescents regarding acne. Pediatr Dermatol 2013;30:3641.Cross Ref linkPubmed link
  • 248  Poli F, Auffret N, Beylot C, et al. Acne as seen by adolescents: results of questionnaire study in 852 French individuals. Acta Derm Venereol 2011;91:5316.Cross Ref linkPubmed link
  • 249  Suthipinittharm P, Noppakun N, Kulthanan K, et al. Opinions and perceptions on acne: a community‐based questionnaire study in Thai students. J Med Assoc Thai 2013;96:9529.Pubmed link
  • 250  Law MP, Chuh AA, Lee A, et al. Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin Exp Dermatol 2010;35:1621.Cross Ref linkPubmed link
  • 251  Ganceviciene R, Graziene V, Bohm M, et al. Increased in situ expression of melanocortin‐1 receptor in sebaceous glands of lesional skin of patients with acne vulgaris. Exp Dermatol 2007;16:54752.Cross Ref linkPubmed link
  • 252  Ganceviciene R, Graziene V, Fimmel S, et al. Involvement of the corticotropin‐releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol 2009;160:34552.Cross Ref linkPubmed link
  • 253  Ganceviciene R, Bohm M, Fimmel S, et al. The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris. Dermatoendocrinology 2009;1:1706.Cross Ref link
  • 254  Albuquerque RG, Rocha MA, Bagatin E, et al. Could adult female acne be associated with modern life? Arch Dermatol Res 2014;306:6838.Cross Ref linkPubmed link
  • 255  Mahe A, Ly F, Aymard G, et al. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 2003;148:493500.Cross Ref linkPubmed link
  • 256  Kane A, Niang SO, Diagne AC, et al. Epidemiologic, clinical, and therapeutic features of acne in Dakar, Senegal. Int J Dermatol 2007;46(Suppl. 1):368.Cross Ref linkPubmed link
  • 257  Plewig G, Fulton JE, Kligman AM. Pomade acne. Arch Dermatol 1970;101:5804.Cross Ref linkPubmed link
  • 258  Mills OH Jr, Kligman AM. Acne detergicans. Arch Dermatol 1975;111:6580.Cross Ref linkPubmed link
  • 259  Gfesser M, Worret WI. Seasonal variations in the severity of acne vulgaris. Int J Dermatol 1996;35:11617.Cross Ref linkPubmed link
  • 260  Tamer E, Ilhan MN, Polat M, et al. Prevalence of skin diseases among pediatric patients in Turkey. J Dermatol 2008;35:41318.Cross Ref linkPubmed link
  • 261  Al‐Ameer AM, Al‐Akloby OM. Demographic features and seasonal variations in patients with acne vulgaris in Saudi Arabia: a hospital‐based study. Int J Dermatol 2002;41:8701.Cross Ref linkPubmed link
  • 262  Jha AK, Gurung D. Seasonal variation of skin diseases in Nepal: a hospital based annual study of out‐patient visits. Nepal Med Coll J 2006;8:2668.Pubmed link
  • 263  Hancox JG, Sheridan SC, Feldman SR, et al. Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. Int J Dermatol 2004;43:611.Cross Ref linkPubmed link
  • 264  Novy FG. Tropical acne. California Med J 1946;115:2746.
  • 265  Jones C, Bleehen SS. Acne induced by PUVA treatment. BMJ 1977;ii:866.Cross Ref link
  • 266  Nielson EB, Thormann J. Acne‐like eruptions induced by PUVA treatment. Acta Derm Venereol (Stockh) 1978;58:3745.
  • 267  Chiba K, Yoshizawa K, Makino I, et al. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci 2000;25:7783.Cross Ref linkPubmed link
  • 268  Suh DH, Kwon TE, Youn JI. Changes of comedonal cytokines and sebum secretion after UV irradiation in acne patients. Eur J Dermatol 2002;12:13944.Pubmed link
  • 269  Ratzer MA. The influence of marriage, pregnancy and childbirth on acne vulgaris. Br J Dermatol 1964;76:1658.Cross Ref linkPubmed link
  • 270  Hızlı D, Kosus A, Kosus N, et al. The impact of birth weight and maternal history on acne, hirsutism, and menstrual disorder symptoms in Turkish adolescent girls. Endocrine 2012;41:4738.Cross Ref linkPubmed link
  • 271  Pandolfi C, Zugaro A, Lattanzio F, et al. Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome. Metabolism 2008;57:9991004.Cross Ref linkPubmed link
  • 272  Mastorakos G, Ilias I. Maternal and fetal hypothalamic–pituitary–adrenal axes during pregnancy and postpartum. Ann NY Acad Sci 2003;997:13649.Cross Ref linkPubmed link
  • 273  Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol 2004;22:3606.Cross Ref linkPubmed link
  • 274  Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol 2005;14:14352.Cross Ref linkPubmed link
  • 275  Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 2009;18:82132.Cross Ref linkPubmed link
  • 276  Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology 2001;203:2779.Cross Ref linkPubmed link
  • 277  Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003;121:207.Cross Ref linkPubmed link
  • 278  Freedberg IM, Tomic‐Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol 2001;116:63340.Cross Ref linkPubmed link
  • 279  Trivedi NR, Gilliland KL, Zhao W, Liu W, Thiboutot DM. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol 2006;126:10719.Cross Ref linkPubmed link
  • 280  Kang S, Cho S, Chung JH, et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor‐kappaB and activator protein‐1 in inflammatory acne lesions in vivo. Am J Pathol 2005;166:16919.Cross Ref linkPubmed link
  • 281  Choi JJ, Park MY, Lee HJ, et al. TNF‐a increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes. J Dermatol Sci 2012;65:17988.Cross Ref linkPubmed link
  • 282  Kistowska M, Gehrke S, Jankovic D, et al. IL‐1b drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol 2014;134:67785.Cross Ref linkPubmed link
  • 283  Kelhälä HL, Palatsi R, Fyhrquist N, et al. IL‐17/Th17 pathway is activated in acne lesions. PLOS One 2014;9(8):e105238.Cross Ref linkPubmed link
  • 284  Alestas T, Ganceviciene R, Fimmel S, Muller‐Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B(4) and prostaglandin E(2) are active in sebaceous glands. J Mol Med 2006;84:7587.Cross Ref linkPubmed link
  • 285  Zhang Q, Seltmann H, Zouboulis CC, Travers JB. Activation of platelet‐activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. Exp Dermatol 2006;15:76974.Cross Ref linkPubmed link
  • 286  Neufang G, Furstenberger G, Heidt M, Marks F, Muller‐Decker K. Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase‐2 in skin. Proc Natl Acad Sci USA 2001;98:762934.Cross Ref linkPubmed link
  • 287  Zhang Q, Seltmann H, Zouboulis CC, Konger RL. Involvement of PPARgamma in oxidative stress‐mediated prostaglandin E(2) production in SZ95 human sebaceous gland cells. J Invest Dermatol 2006;126:428.Cross Ref linkPubmed link
  • 288  Zouboulis CC, Seltmann H, Alestas T. Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis. Exp Dermatol 2009;19:14850.Cross Ref linkPubmed link
  • 289  Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC. Corticotropin‐releasing hormone skin signaling is receptor‐mediated and is predominant in the sebaceous glands. Horm Metab Res 2007;39:6670.Cross Ref link
  • 290  Zouboulis CC, Seltmann H, Hiroi N, et al. Corticotropin‐releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA 2002;99:714853.Cross Ref linkPubmed link
  • 291  Thody AJ, Cooper MF, Bowden PE, Meddis D, Shuster S. Effect of alpha‐melanocyte‐stimulating hormone and testosterone on cutaneous and modified sebaceous glands in the rat. J Endocrinol 1976;71:27988.Cross Ref linkPubmed link
  • 292  Zhang L, Li WH, Anthonavage M, Eisinger M. Melanocortin‐5 receptor: a marker of human sebocyte differentiation. Peptides 2006;27:41320.Cross Ref linkPubmed link
  • 293  Böhm M, Schiller M, Ständer S, et al. Evidence for expression of melanocortin‐1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol 2002;118:5339.Cross Ref linkPubmed link
  • 294  Bhardwaj R, Becher E, Mahnke K, et al. Evidence for the differential expression of the functional alpha‐melanocyte‐stimulating hormone receptor MC‐1 on human monocytes. J Immunol 2007;158:337884.
  • 295  Hartmeyer M, Scholzen T, Becher E, et al. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL‐8 upon stimulation with alpha‐melanocyte‐stimulating hormone. J Immunol 1997;159:19307.Pubmed link
  • 296  Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol 2004;22:3606.Cross Ref linkPubmed link
  • 297  Toyoda M, Nakamura M, Morohashi M. Neuropeptides and sebaceous glands. Eur J Dermatol 2002;12:4227.Pubmed link
  • 298  Thielitz A, Reinhold D, Vetter R, et al. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation. J Invest Dermatol 2007;127:104251.Cross Ref linkPubmed link
  • 299  Fitz‐Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 2013;133:215260.Cross Ref linkPubmed link
  • 300  Jasson F, Nagy I, Knol AC, et al. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity. Exp Dermatol 2013;22:58792.Cross Ref linkPubmed link
  • 301  Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 2006;8:2195205.Cross Ref linkPubmed link
  • 302  Nagy I, Pivarcsi A, Koreck A, et al. Distinct strains of Propionibacterium acnes induce selective human beta‐defensin‐2 and interleukin‐8 expression in human keratinocytes through toll‐like receptors. J Invest Dermatol 2005;124:9318.Cross Ref linkPubmed link
  • 303  Schaller M, Loewenstein M, Borelli C, et al. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III. Br J Dermatol 2005;153:6671.Cross Ref linkPubmed link
  • 304  Agak GW, Qin M, Nobe J, et al. Propionibacterium acnes induces an IL‐17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J Invest Dermatol 2014;134:36673.Cross Ref linkPubmed link
  • 305  Kistowska M, Meier B, Proust T, et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol 2015;135:11018.Cross Ref linkPubmed link
  • 306  Kistowska M, Gehrke S, Jankovic D, et al. IL‐1b drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol 2014;134:67785.Cross Ref linkPubmed link
  • 307  Li ZJ, Choi DK, Sohn KC, et al. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol 2014;134:274756.Cross Ref linkPubmed link
  • 308  Kim J. Review of the innate immune response in acne vulgaris: activation of Toll‐like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 2005;211:1938.Cross Ref linkPubmed link
  • 309  Georgel P, Crozat K, Lauth X, et al. A toll‐like receptor 2‐responsive lipid effector pathway protects mammals against skin infections with gram‐positive bacteria. Infect Immun 2005;73:451221.Cross Ref linkPubmed link
  • 310  Oeff MK, Seltmann H, Hiroi N, et al. Differential regulation of Toll‐like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 2006;213:266.Cross Ref linkPubmed link
  • 311  Selway JL, Kurczab T, Kealey T, Langlands K. Toll‐like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne. BMC Dermatol 2013;13:10.Cross Ref linkPubmed link
  • 312  Bakry OA, Samaka RM, Sebika H, Seleit I. Toll‐like receptor 2 and P. acnes: do they trigger initial acne vulgaris lesions? Anal Quant Cytopathol Histpathol 2014;36:10010.Pubmed link
  • 313  Chronnell CMT, Ghali LR, Ali RS, et al. Human beta defensin‐1 and ‐2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol 2001;117:11205.Cross Ref linkPubmed link
  • 314  Lee DY, Yamasaki K, Rudsil J, et al. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J Invest Dermatol 2008;128:18636.Cross Ref linkPubmed link
  • 315  Graham GM, Farrar MD, Cruse‐Sawyer JE, Holland KT, Ingham E. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 2004;150:4218.Cross Ref linkPubmed link
  • 316  McDowell A, Valanne S, Ramage G, et al. Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol 2005;43:32634.Cross Ref linkPubmed link
  • 317  Georgel P, Crozat K, Lauth X, et al. A toll‐like receptor 2‐responsive lipid effector pathway protects mammals against skin infections with gram‐positive bacteria. Infect Immun 2005;73:451221.Cross Ref linkPubmed link
  • 318  Harrison WJ, Bull JJ, Seltmann H, Zouboulis CC, Philpott MP. Expression of lipogenic factors galectin‐12, resistin, SREBP‐1, and SCD in human sebaceous glands and cultured sebocytes. J Invest Dermatol 2007;127:130917.Cross Ref linkPubmed link
  • 319  Nakatsuji T, Kao MC, Fang JY, et al. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 2009;129:24808.Cross Ref linkPubmed link
  • 320  Nakatsuji T, Kao MC, Zhang L, et al. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta‐defensin‐2 expression. J Invest Dermatol 2010;130:98594.Cross Ref linkPubmed link
  • 321  Sneddon J, Sneddon I. Acne excoriée: a protective device. Clin Exp Dermatol 1983;8:658.Cross Ref linkPubmed link
  • 322  Gupta MA, Gupta AK, Schork NJ. Psychosomatic study of self‐excoriative behaviour among male acne patients: preliminary observations. Int J Dermatol 1994;33:8468.Cross Ref linkPubmed link
  • 323  Gupta MA, Gupta AK. Psychodermatology: an update. J Am Acad Dermatol 1996;34:103046.Cross Ref linkPubmed link
  • 324  Kranke B, Brabek E, Derhaschnig J, et al. Acne excoriata: look for allergy! Dermatology 2001;203:2567.Cross Ref linkPubmed link
  • 325  Gieler U, Consoli SG, Tomas‐Aragones L, et al. Self‐inflicted lesions in dermatology: terminology and classification. A position paper from the European Society for Dermatology and Psychiatry (ESDaP). Acta Derm Venereol 2013;93:412.Pubmed link
  • 326  Shenefelt PD. Using hypnosis to facilitate resolution of psychogenic excoriations in acne excoriee. Am J Clin Hypn 2004;46:23945.Cross Ref linkPubmed link
  • 327  Kent A, Drummond LM. Acne excoriee: a case report using habit reversal. Clin Exp Dermatol 1989;14:1634.Cross Ref linkPubmed link
  • 328  Bowes LE, Alster TS. Treatment of facial scarring and ulceration resulting from acne excoriée with the 585‐nm pulsed dye laser irradiation and cognitive psychotherapy. Dermatol Surg 2004;30:9348.Pubmed link
  • 329  Cotterill JA. Dermatological non‐disease: a common and potentially fatal disturbance of cutaneous body image. Br J Dermatol 1981;104:61119.Cross Ref linkPubmed link
  • 330  Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997;137:24650.Cross Ref linkPubmed link
  • 331  Hull SM, Cunliffe WJ, Hughes BR. Treatment of the depressed and dysmorphophobic acne patient. Clin Exp Dermatol 1991;16:21011.Cross Ref linkPubmed link
  • 332  Strumia R. Skin signs in anorexia nervosa. Dermatoendocrinology 2009;1:26870.Cross Ref link
  • 333  Peachey RDG, Matthews CNA. ‘Fiddler's neck’. Br J Dermatol 1978;98:66974.Cross Ref linkPubmed link
  • 334  Goldman L. Turtleneck shirt and sweater acne [Letter]. Arch Dermatol 1977;113:109.Cross Ref linkPubmed link
  • 335  MacGregor AJ, Cunliffe WJ, Tan SG. Acne mechanica. BMJ 1976;i:1301.
  • 336  Strauss RM, Harrington CI. Stump acne: a new variant of ance mechanica and a cause of immobility. Br J Dermatol 2001;144:6478.Cross Ref linkPubmed link
  • 337  Daley TD. Intraoral sebaceous hyperplasia. Diagnostic criteria. Oral Surg Oral Med Oral Pathol 1993;75:3437.Cross Ref linkPubmed link
  • 338  Monk BE. Fordyce spots responding to isotretinoin therapy. Br J Dermatol 1993;129:355.Cross Ref linkPubmed link
  • 339  Campo‐Candriani J, Villarreal‐Rodriquez A, Quinones‐Fernandez AG, et al. Treatment of Fordyce spots with CO2 laser. Dermatol Surg 2003;29:86971.Pubmed link
  • 340  Tsuji T, Yamauchi R. Areolar sebaceous hyperplasia with a Fordyce's spot‐like lesion. J Dermatol 1994;21:5246.Cross Ref linkPubmed link
  • 341  Cunliffe WJ, Ead RD, Perera WHD, et al. An acne‐free naevus. Br J Dermatol 1977;96:28790.Cross Ref linkPubmed link
  • 342  Betiman C. Über den Naevus acneiformis. Arch Dermatol Syphilol 1906;80:636.Cross Ref link
  • 343  White CJ. Naevus follicularis keratosus. J Cutan Dis 1914;32:18790.
  • 344  Marsden RA, Fleming K, Dawber RPR. Comedo naevus of the palm: a sweat duct naevus? Br J Dermatol 1979;101:71722.Cross Ref linkPubmed link
  • 345  Abdel‐Aal H, Abdel‐Aziz AHM. Nevus comedonicus: report of three cases localized on glans penis. Acta Derm Venereol (Stockh) 1975;55:7880.
  • 346  Beck MH, Dave VK. Extensive nevus comedonicus. Arch Dermatol 1980;116:104850.Cross Ref linkPubmed link
  • 347  Barsky S, Doyle JA, Winkelmann RK. Nevus comedonicus with epidermolytic hyperkeratosis. A report of four cases. Arch Dermatol 1981;117:869.Cross Ref linkPubmed link
  • 348  Baxter K, Highet A, Cunliffe WJ. An unusual late onset closed‐comedone naevus: successful therapy with light cautery and a topical retinoid. J Dermatol Treat 2004;15:589.Cross Ref link
  • 349  Munro CS, Wilkie AO. Epidermal mosaicism producing localized acne: somatic mutation in FGFR2. Lancet 1998;352:7045.Cross Ref linkPubmed link
  • 350  Melnik B, Vakilzadeh F, Aslandis C, et al. Unilateral segmental nevus: a model disorder towards understanding FGFR2 function in acne? Br J Dermatol 2008;158:13979.Cross Ref linkPubmed link
  • 351  Mehregan AH, Pinkus H. Life history of organoid naevi. Special reference to naevus sebaceous of Jadassohn. Arch Dermatol 1965;91:57488.Cross Ref linkPubmed link
  • 352  Lantis S, Leyden JE, Thew M, Heaton C. Naevus sebaceous of Jadassohn: part of a new neurocutaneous syndrome? Arch Dermatol 1968;98:11723.Cross Ref linkPubmed link
  • 353  Fergin PE, Chu AC, MacDonald DM. Basal cell carcinoma complicating naevus sebaceous. Clin Exp Dermatol 1981;6:11115.Cross Ref linkPubmed link
  • 354  Weigl L, Eberlein‐Konig B, Ring J. Eccrine syringofibroadenoma developing in a sebaceous naevus. Br J Dermatol 2000;142:104950.Cross Ref link
  • 355  Rendlemann L, Stone MS. An unusual hematopoietic proliferation seen in a nevus sebaceous. J Am Acad Dermatol 2000;42:8812.Cross Ref linkPubmed link
  • 356  Stefanidou M, Ioannidou D, Tosca A. Unilateral nodular elastosis with cysts and comedones (Favre–Racouchot syndrome). Dermatology 2001;207:2701.Cross Ref link
  • 357  De Berker DAR, Taylor AE, Quinn AG, et al. Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes? J Am Acad Dermatol 1996;35:6969.Cross Ref linkPubmed link
  • 358  Ahassi D, Gonzalez E, Anderson RR, et al. Elucidating the pulsed‐dye laser treatment of sebaceous hyperplasia in vivo with real‐time confocal scanning laser microscopy. J Am Acad Dermatol 2000;43:4953.Cross Ref linkPubmed link
  • 359  No D, McClaren M, Chotzen V. Sebaceous hyperplasia treated with a 1450 nm diode laser. Dermatol Surg 2004;30:3834.
  • 360  Gollnick H, Orfanos CE. Front facial picture of a lady with familial nevoid sebaceous hyperplasia before and after treatment with isotretinoin. In: Wilkinson DS, Mascaro JM, Orfanos CE, eds. Clinical Dermatology. The CMD Case Collection. Stuttgart: Schattauer, 1987:3502.
  • 361  Richey DF. Aminolevulinic acid photodynamic therapy for sebaceous gland hyperplasia. Dermatol Clin 2007;25:5965.Cross Ref linkPubmed link
  • 362  Torré D. Multiple sebaceous tumors. Arch Dermatol 1968;98:54952.Cross Ref linkPubmed link
  • 363  Davis DA, Cohen PR. Genitourinary tumors in men with the Muir–Torré syndrome. J Am Acad Dermatol 1995;33:90912.Cross Ref linkPubmed link
  • 364  Schwartz RA, Torré DP. The Muir–Torré syndrome: a 25 year retrospect. J Am Acad Dermatol 1995;33:90104.Cross Ref linkPubmed link
  • 365  Hall NR, Murday VA, Chapman P, et al. Genetic linkage in Muir–Torré syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer 1994;30A:1802.Cross Ref linkPubmed link
  • 366  Lachiewicz AM, Wilkinson JM, Groben P, et al. Muir–Torre syndrome. Am J Clin Dermatol 2007;8:21519.Cross Ref link
  • 367  Brauninger GE, Hood CI, Worthen DM. Sebaceous carcinoma of lid margin masquerading as cutaneous horn. Arch Ophthalmol 1973;90:3801.Cross Ref linkPubmed link
  • 368  Matsumoto CS, Nakatsuka K, Matsuo K, et al. Sebaceous carcinoma responds to radiation therapy. Ophthalmologica 1995;209:2803.Cross Ref linkPubmed link
  • 369  Saito A, Tsutsumida A. Sebaceous carcinoma of the eyelids: a review of 21 ases. J Plast Reconstr Aesthetic Surg 2008;61:132831.Cross Ref link
  • 370  Amerlinck F. Sébocystomatose héréditaire. Arch Belg Dermatol Syphiligr 1949;5:18791.Pubmed link
  • 371  Egbert DM, Price NM, Segal RJ. Steatocystoma multiplex. Report of a florid case and a review. Arch Dermatol 1979;115:3345.Cross Ref linkPubmed link
  • 372  Plewig G, Wolff HH, Braun‐Falco D. Steatocytoma multiplex: anatomic re‐evaluation, electron microscopy, and autoradiography. Arch Dermatol Res 1982;272:36380.Cross Ref linkPubmed link
  • 373  Cho S, Chang SE, Choi JH, et al. Clinical and histological features of 64 cases of steatocystoma multiplex. J Dermatol 2002;29:1526.Cross Ref linkPubmed link
  • 374  Murray FA. Congenital anomalies of nails associated with teeth erupted at birth. Br J Dermatol 1921;33:40916.Cross Ref link
  • 375  Jackson AD, Lawler SD. Pachyonychia congenita: a report on six cases in one family. Ann Eugen 1951;16:1426.Cross Ref linkPubmed link
  • 376  Clementi M, Cardin de Stefani E, Dei Rossi C, et al. Pachyonychia congenita Jackson–Lawler type: a distinct malformation syndrome. Br J Dermatol 1986;114:36770.Cross Ref linkPubmed link
  • 377  Oh SW, Kim MY, Lee JS, et al. Keratin 17 mutation in pachyonychia congenita type 2 with early onset steatocystoma multiplex and Hutchinson‐like tooth deformity. J Dermatol 2006;33:1614.Cross Ref linkPubmed link
  • 378  McDonald RM, Reed WB. Natal teeth and steatocystoma multiplex complicated by hidradenitis suppurativa. Arch Dermatol 1975;112:11324.Cross Ref link
  • 379  Moon SE, Lee YS, Young JI. Eruptive vellus hair cyst and steatocystoma multiplex in a patient with pachyonychia congenita. J Am Acad Dermatol 1994;30:2756.Cross Ref linkPubmed link
  • 380  McLean WHI, Rugg EL, Lunny DP, et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet 1995;9:2738.Cross Ref linkPubmed link
  • 381  Smith FJD, Corden LD, Rugg EL, et al. Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997;108:2203.Cross Ref linkPubmed link
  • 382  Feng YG, Xiao SX, Ren XR, et al. Keratin 17 mutation in pachyonychia congenita type 2 with early onset sebaceous cysts. Br J Dermatol 2003;148:4525.Cross Ref linkPubmed link
  • 383  King NM, Lee AMP. Natal teeth and steatocystoma multiplex: a newly recognised syndrome. J Craniofac Genet Dev Biol 1987;7:31117.Pubmed link
  • 384  Lee SJ, Choe YS, Park BC, et al. The vein hook successfully used for eradication of steatocystoma multiplex. Dermatol Surg 2007;33:826.Pubmed link
  • 385  Rossi R, Cappugi P, Battini M, et al. CO2 laser therapy in a case of steatocystoma multiplex with prominent nodules on the face. Int J Dermatol 2003;42:3024.Cross Ref linkPubmed link
  • 386  Hwang S, Schwartz RA. Keratosis pilaris: a common follicular hyperkeratosis. Cutis 2008;82:17780.Pubmed link
  • 387  Poskitt L, Wilkinson JD. Natural history of keratosis pilaris. Br J Dermatol 1994;130:71113.Cross Ref linkPubmed link
  • 388  Zouboulis CC, Stratakis CA, Gollnick HP, et al. Keratosis pilaris/ulerythema ophryogenes and 18p depletion: is it possible that the LAMA1 gene is involved? J Med Genet 2001;38:1278.Cross Ref linkPubmed link
  • 389  Schmitt JV, Lima BZ, Souza MCMR, et al. Keratosis pilaris and prevalence of acne vulgaris a cross sectional study. An Bras Dermatol 2014;89:915.Cross Ref linkPubmed link
  • 390  Fulton JE, McGinley K, Leyden J, et al. Gram‐negative folliculitis in acne vulgaris. Arch Dermatol 1968;98:34953.Cross Ref linkPubmed link
  • 391  Leyden JJ, Marples RR, Mills OK. Gram negative folliculitis: a complication of antibiotic therapy in acne vulgaris. Br J Dermatol 1973;88:5338.Cross Ref linkPubmed link
  • 392  Leyden JJ, McGinley KJ, Mills OH. Pseudomonas aeruginosa Gram negative folliculitis. Arch Dermatol 1979;115:12034.Cross Ref linkPubmed link
  • 393  James WD, Leyden JJ. Treatment of Gram‐negative folliculitis with isotretinoin: positive clinical and microbiologic response. J Am Acad Dermatol 1985;12:31924.Cross Ref linkPubmed link
  • 394  Plewig C, Nikolowski J, Wolff HH. Action of isotretinoin in acne rosacea and Gram‐negative folliculitis. J Am Acad Dermatol 1982;6:76685.Cross Ref linkPubmed link
  • 395  Boni R, Nehroff B. Treatment of Gram negative folliculitis in acne patients. Am J Clin Dermatol 2003;4:2736.Cross Ref linkPubmed link
  • 396  Ford CP, Ive FA, Midgley G. Pityrosporum folliculitis and ketoconazole. Br J Dermatol 1982;107:6915.Cross Ref linkPubmed link
  • 397  Faergemann J. Pityrosporum infections. J Am Acad Dermatol 1994;31(3 Pt 2):S1820.Cross Ref linkPubmed link
  • 398  Hughes BR, Cunliffe WJ. Development of folliculitis and pyoderma gangrenosum in association with abdominal pain in a patient following treatment with isotretinoin. Br J Dermatol 1990;122:6837.Cross Ref linkPubmed link
  • 399  Esmat SM, Abdel Hay RM, Abu Zeid OM, et al. The efficacy of laser‐assisted hair removal in the treatment of acne keloidalis nuchae: a pilot study. Eur J Dermatol 2012;22:6455.Pubmed link
  • 400  Alexis A, Heath CR, Halder RM. Folliculitis keloidalis nuchae and pseudofolliculitis barbae: are prevention and effective treatment within reach? Dermatol Clin 2014;32:18391.Cross Ref linkPubmed link
  • 401  Karakuzu A, Erdem, T, Aktas A, et al. A case of folliculitis decalvans involving the beard, face and nape. J Dermatol 2001;28:32931.Cross Ref linkPubmed link
  • 402  Powell JJ, Dawber RPR, Gatter K. Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 1999;140:32833.Cross Ref linkPubmed link
  • 403  Brooke RC, Griffiths CEM. Folliculitis decalvans. Clin Exp Dermatol 2001;26:1202.Cross Ref linkPubmed link
  • 404  Kaur S, Kanwar AJ. Folliculitis decalvans: successful treatment with a combination of rifampicin and topical mupirocin. J Dermatol 2002;29:1801.Cross Ref linkPubmed link
  • 405  Gemmeke A, Wollina U. Folliculitis decalvans of the scalp: response to triple therapy with isotretinoin, clindamycin and prednisolone. Acta Dermatovenereol Alp Panonica Adriat 2006;15:1846.
  • 406  Abdeck D, Korting HC, Braun‐Falco O. Folliculitis decalvans. Long lasting response to combined therapy with fusidic acid and zinc. Acta Derm Venereol 1992;72:1435.Pubmed link
  • 407  Kunte C, Loeser C, Wolff H. Folliculitis spinulosa decalvans: successful treatment with dapsone. J Am Acad Dermatol 1998;39:8913.Cross Ref linkPubmed link
  • 408  Smith EP, Hardaway CA, Graham BS, et al. Folliculitis decalvans treated with radiation therapy. Cutis 2006;78:1624.Pubmed link
  • 409  Sivakumaran S, Meyer P, Burrows NP. Dissecting folliculitis of the scalp with marginal keratitis. Clin Exp Dermatol 2001;26:4902.Cross Ref linkPubmed link
  • 410  Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobata with oral zinc. Br J Dermatol 1999;141:11378.Cross Ref linkPubmed link
  • 411  Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin. Eur J Dermatol 2003;13:1925.Pubmed link
  • 412  Ljubojevic S, Pasic A, Lipozencic J, et al. Perifolliculitis capitis abscendens et suffodiens. J Eur Acad Dermatol Venereol 2005;19:71921.Cross Ref linkPubmed link
  • 413  Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J 2003;9(1):8.Pubmed link
  • 414  Chicarilli ZN. Follicular occlusion triad: hidradenitis suppuritiva, acne conglobate and dissecting cellulitis of the scalp. Ann Plast Surg 1987;18:2307.Cross Ref linkPubmed link
  • 415  Prasad SC, Bygum A. Successful treatment with alitretinoin of dissecting cellulitis of the scalp in keratitis–ichthyosis–deafness syndrome. Acta Derm Venereol 2013;93:4734.Cross Ref linkPubmed link
  • 416  Jansen T, Altmeyer P, Plewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol 2001;15:53240.Cross Ref linkPubmed link
  • 417  Von der Werth JM, Jemec GBE. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001;144:80913.Cross Ref linkPubmed link
  • 418  Von der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000;142:94753.Cross Ref linkPubmed link
  • 419  Palmer RA, Keefe M. Early onset hidradenitis suppurativa. Clin Exp Dermatol 2001;26:5013.Cross Ref linkPubmed link
  • 420  Georgousas K, Kocsard E. Micropapular sarcoidal facial eruption in a child. Gianotti‐type perioral dermatitis. Acta Derm Venereol (Stockh) 1978;58:4336.
  • 421  Schlappner OLA, Shelley WB, Ruberg RL, Dudrick SJ. Acute papulopustular acne, associated with prolonged intravenous hyperalimentation. JAMA 1972;219:87780.Cross Ref linkPubmed link
  • 422  Kossard S, Collins A, McCrossin I. Necrotizing lymphocytic folliculitis: the early lesion of acne necrotica (varioliformis). J Am Acad Dermatol 1987;16:100714.Cross Ref linkPubmed link
  • 423  Maibach HI. Acne necroticans (varioliformis) versus Propionibacterium acnes folliculitis. J Am Acad Dermatol 1989;21:323.Cross Ref linkPubmed link
  • 424  Barratt H, Hamilton F, Car J, et al. Outcome measures in acne vulgaris: systematic review. Br J Dermatol 2009;160:1326.Cross Ref linkPubmed link
  • 425  Patwardhan SV, Kaczvinsky JR, Joa JF, Canfield D. Auto‐classification of acne lesions using multimodal imaging. J Drugs Dermatol 2013;12:74656.Pubmed link
  • 426  Warburton K, Whitehouse H, El‐Naes R, et al. How people with acne decide if their treatment is working. Br J Dermatol 2014;171:38.Cross Ref linkPubmed link
  • 427  O'Brien SC, Lewis JB, Cunliffe WJ. The Leeds revised acne grading scale. J Dermatol Treat 1998;9:21520.Cross Ref link
  • 428  Tan J, Tang J, Fung K, et al. Development and validation of a comprehensive acne severity scale (CASS). J Cutan Med Surg 2007;11:21116.Cross Ref linkPubmed link
  • 429  Lucky AW, Barber BL, Girman CJ, et al. A multirotor validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol 1996;35:55965.Cross Ref linkPubmed link
  • 430  Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg 1998;17:2916.Cross Ref linkPubmed link
  • 431  Gupta MA, Johnson AM, Gupta AK. The development of an Acne Quality of Life Scale: reliability, validity and relation to the subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol (Stockh) 1998;78:4518.Cross Ref link
  • 432  Leyden JJ. New understandings of the pathogenesis of acne. J Am Acad Dermatol 1995;32(5 Pt 3):S1525.Cross Ref linkPubmed link
  • 433  Agache P. Sebaceous functions assessment. In: Agache P, Philippe H, eds. Measuring the Skin. Berlin: Springer‐Verlag, 2004:281.Cross Ref link
  • 434  Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20:4259.Cross Ref linkPubmed link
  • 435  Cunliffe WJ. Unemployment and acne. Br J Dermatol 1986;115:386.Cross Ref linkPubmed link
  • 436  Wu SF, Kinder BN, Trunnell TN, et al. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol 1988;18:32533.Cross Ref linkPubmed link
  • 437  Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with medical conditions using questionnaires. Br J Dermatol 1999;140:6726.Cross Ref linkPubmed link
  • 438  Feingolg A. Good‐looking people are not what we think. Psychol Bull 1992;111:30441.Cross Ref link
  • 439  Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:84650.Cross Ref linkPubmed link
  • 440  Garrie S, Garrie E. Anxiety and skin diseases. Cutis 1979;22:2058.
  • 441  Patel MJ, Antony A, Do TT, et al. Atrophic acne scars may arise from both inflammatory and non‐inflammatory acne lesions. J Invest Dermatol 2010;130(Suppl. 1s):S58.
  • 442  Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol 1994;1:3038.Cross Ref link
  • 443  Holland DB, Jeremy AH, Roberts SG, et al. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. Br J Dermatol 2004;150:7281.Cross Ref linkPubmed link
  • 444  Finlay AY, Torres V, Kang S, et al. Classification of acne scars is difficult even for acne experts. J Eur Acad Dermatol Venereol 2013;27:3913.Cross Ref linkPubmed link
  • 445  Verdi DP, Saqueton AC. Perifollicular elastolysis. Br J Dermatol 1970;83:14350.Cross Ref linkPubmed link
  • 446  Leider M. Osteoma cutis as a result of severe acne vulgaris of long duration. Arch Dermatol Syphilol 1950;62:4057.Cross Ref link
  • 447  MacGregor A. Calcification in scars of healed acne vulgaris. Oral Surg Oral Med Oral Pathol 1971;32:82930.Cross Ref linkPubmed link
  • 448  Camcho‐Martinez F, Winkelmann RK. Solid facial edema as a manifestation of acne. J Am Acad Dermatol 1990;22:12930.Cross Ref linkPubmed link
  • 449  Tosti A, Guerra L, Bettoli V. Solid facial edema as a complication of acne vulgaris in twins. J Am Acad Dermatol 1987;17:8434.Cross Ref linkPubmed link
  • 450  Uhara H, Kawachi S, Saida T. Solid facial edema in a patient with rosacea. J Dermatol 2000;27:21416.Cross Ref linkPubmed link
  • 451  Freidman SJ, Fox BJ, Albert HL. Solid edema as a complication of acne vulgaris: treatment with isotretinoin. J Am Acad Dermatol 1986;15:2869.Cross Ref linkPubmed link
  • 452  Jungfer B, Jansen T, Przbilla G. Solid facial edema of acne: successful treatment with isotretinoin and ketotifen. Dermatology 1993;187:347.Cross Ref linkPubmed link
  • 453  Helander I, Aho HJ. Solid facial edema as a complication of acne vulgaris: treatment with isotretinoin and clofazimine. Acta Derm Venereol (Stockh) 1987;67:5357.
  • 454  Basler RGW, Taylor WB, Peacor DR. Post‐acne osteoma. Arch Dermatol 1974;110:11314.Cross Ref linkPubmed link
  • 455  Monteiro M, Koblenzer C. Multiple osteoma cutis lesions associated with acne. Int J Dermatol 2000;39:5534.Cross Ref linkPubmed link
  • 456  Cunliffe WJ, Holland DB, Clark SM, et al. Comedogenesis: some aetiological, clinical and therapeutic strategies. Dermatology 2003;206:1116.Cross Ref linkPubmed link
  • 457  Cohen AD, Chetov T, Cagnano E, et al. Treatment of multiple miliary osteoma cutis of the face with local application of tretinoin (all‐trans‐retinoic‐acid): a case report and review of the literature. J Dermatol Treat 2001;12:1713.Cross Ref link
  • 458  Smith CG, Galser DA. Treatment of multiple miliary osteoma cutis with tretinoin gel. J Am Acad Dermatol 1999;41:500.Cross Ref linkPubmed link
  • 459  Fulton JE Jr. Dermabrasion‐Loo‐punch‐excision technique for the treatment of acne‐induced osteoma cutis. J Dermatol Surg Oncol 1987;13:6559.Cross Ref linkPubmed link
  • 460  Altman JF, Nehal KS, Halpern AC, et al. Treatment of miliary osteoma cutis with incision, curettage and primary closure. J Am Acad Dermatol 2001;44:969.Cross Ref linkPubmed link
  • 461  Baskan EB, Turan H, Tunali S, et al. Miliary osteoma cutis of the face: treatment with needle microincision‐extirpation method. J Dermatol Treat 2007;18:2524.Cross Ref link
  • 462  Ochsendorf FR, Kaufmann R. Erbium‐YAG laser‐assisted treatment of miliary osteoma cutis. Br J Dermatol 1998;138:3712.Cross Ref linkPubmed link
  • 463  Ochsendorf FR, Kaufmann R. Erbium‐YAG laser ablation for osteoma cutis: modification of approach. Arch Dermatol 1999;135:1416.Cross Ref linkPubmed link
  • 464  Mobayen MM, Copeman PWM. Multiple pyogenic granuloma in secondarily infected cystic acne. Clin Exp Dermatol 1983;8:1079.Cross Ref linkPubmed link
  • 465  Miller RAW, Ross JB. Multiple granulation tissue lesions occurring in isotretinoin treatment of acne vulgaris. J Am Acad Dermatol 1985;12:8889.Cross Ref linkPubmed link
  • 466  Cunliffe WJ, Shuster S. Pathogenesis of acne. Lancet 1969;i:6857.Cross Ref linkPubmed link
  • 467  Gollnick HP, Finlay AY, Shear N, et al. Can we define acne as a chronic disease? If so, how and when? Am J Dermatol 2008;9:27984.Cross Ref link
  • 468  Leyden JJ. Therapy for acne vulgaris. N Engl J Med 1997;336:115662.Cross Ref linkPubmed link
  • 469  Cunliffe WJ, Clayden AD, Gould D, et al. Acne vulgaris: its aetiology and treatment. A review. Clin Exp Dermatol 1981;6:4619.Cross Ref linkPubmed link
  • 470  Thiboutot D. New treatment and therapeutic strategies for acne. Arch Fam Med 2000;9:17987.Cross Ref linkPubmed link
  • 471  Nast A, Dréno B, Bettoli V, et al. European evidence‐based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012;26(Suppl. 1):129.Cross Ref linkPubmed link
  • 472  Dreno B, Bettoli V, Ochsendorf F, et al. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 2006;15:56571.
  • 473  Shalita AR, Chalker DK, Griffith RF, et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicentre double‐blind randomised controlled study. Cutis 1999;63:34953.Pubmed link
  • 474  Webster GF, Berson D, Stein LF, et al. Efficacy and tolerability of once‐daily tazarotene 0.0% gel vs once‐daily 0.025% gel in the treatment of facial acne vulgaris: a randomised trial. Cutis 2001;67:1727.Pubmed link
  • 475  Christophers E, Wolfe HH. Effect of vitamin A acid on skin: in vivo and in vitro studies. Acta Derm Venereol (Stockh) 1975;74:4253.
  • 476  Lyons RE. Comparative effectiveness of benzoyl peroxide and tretinoin in acne vulgaris. Int J Dermatol 1978;17:24651.Cross Ref linkPubmed link
  • 477  Leyden J, Shalita AR. Rational therapy for acne vulgaris: an update on topical treatment. J Am Acad Dermatol 1986;15:90715.Cross Ref linkPubmed link
  • 478  Bouclier M, Chatelus A, Ferracin J, et al. Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique. Skin Pharmacol 1991;4:6573.Cross Ref linkPubmed link
  • 479  Liu PT, Krutzik SR, Kim J, et al. Cutting edge: all‐trans retinoic acid down regulates TLR2 expression and function. J Immunol 2005;174:246770.Cross Ref linkPubmed link
  • 480  Tenaud I, Khamamari A, Dreno B. In vitro modulation of TLR‐2, CD1d and IL‐10 by adapalene on normal human skin and inflammatory lesions. Exp Dermatol 2007;16:5006.Cross Ref linkPubmed link
  • 481  Jones DA. The potential immunomodulatory effects of topical retinoids. Dermatol Online J 2005;11(1):3.Pubmed link
  • 482  Lehman HP, Andrews JS, Robinson KA, Holloway VL, Goodman SN. Management of acne. Evidence Report/Technology Assessment No. 17. Rockville, MD: Agency for Healthcare Research and Quality, 2001.
  • 483  Cunliffe WJ, Poncet M, Loesche C, et al. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta‐analysis of five randomised trials. Br J Dermatol 1998;139(Suppl. 52):4856.Cross Ref linkPubmed link
  • 484  Cunliffe WJ, Holland KT. The effect of benzoyl peroxide on acne. Acta Derm Venereol (Stockh) 1981;61:2679.
  • 485  Bojar RA, Cunliffe WJ, Holland KT. The short‐term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol 1995;132:2048.Cross Ref linkPubmed link
  • 486  Fulton JE, Farzad‐Batshandeth A. Studies on the mechanism of action of topical benzoyl peroxide in acne vulgaris. J Cutan Pathol 1974;1:194200.Cross Ref link
  • 487  Handojo I. The combined use of topical benzoyl peroxide and tretinoin in the treatment of acne vulgaris. Int J Dermatol 1979;18:48996.Cross Ref linkPubmed link
  • 488  Draelos ZD, Carter E, Maloney JM, et al. Two randomized studies demonstrate the efficacy and safety of topical dapsone gel 5% in the treatment of acne vulgaris. J Am Acad Dermatol 2007;56:439e110.
  • 489  Silva A, Gollnick H, Detmar M, et al. Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin. Acta Derm Venereol (Stockh) 1989;143:2030.
  • 490  Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol Suppl (Stockh) 1989;143:359.Pubmed link
  • 491  Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris. J Am Acad Dermatol 1996;34:4825.Cross Ref linkPubmed link
  • 492  Alirezai M, Meynadier J, Jablonski S, et al. Étude comparative de l'efficacité de la tolérance des gels d'apalana à 0.1% et 0.03% et d'un gel de trétinoine à 0.025%. Arch Dermatol Vénéréol 1996;123:16570.
  • 493  Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996;34:4825.Cross Ref linkPubmed link
  • 494  Caron D, Sorba V, Kerrouche N, Clucas A. Split‐face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J Am Acad Dermatol 1997;36(6 Pt 2):S11012.Cross Ref linkPubmed link
  • 495  Shalita AR, Chalker DK, Griffith RF, et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicentre double‐blind randomised controlled study. Cutis 1999;63:34953.Pubmed link
  • 496  Webster GF, Berson D, Stein LF, et al. Efficacy and tolerability of once‐daily tazarotene 0.1% gel versus once‐daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. Cutis 2001;67(6 Suppl.):49.Pubmed link
  • 497  Elbaum DJ. Comparison of the stability and safety of topical isotretinoin and topical tretinoin and their efficacy in acne. J Am Acad Dermatol 1988;19:48691.Cross Ref linkPubmed link
  • 498  Schaefer H. Penetration and percutaneous absorption of topical retinoids. A review. Skin Pharmacol 1993;6:1723.Cross Ref linkPubmed link
  • 499  Chu A, Huber FJ, Plott RT. The comparative efficacy of benzoyl peroxide, 5% erythromycin gel, 3% gel and erythromycin 4% zinc 1–2% solution in the treatment of acne vulgaris. Br J Dermatol 1997;136:2358.Cross Ref linkPubmed link
  • 500  Eady EA, Cope JH, Jones DN, et al. Topical antibiotics for the treatment of acne: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treat 1990;1:21526.Cross Ref link
  • 501  Garner SE, Eady EA, Popescu C, Newton J, Li WA. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2003;(1):CD002086.Pubmed link
  • 502  Garner SE. Acne vulgaris. In: Williams H, ed. Evidence‐Based Dermatology. London: BMJ Publishing, 2003:87114.
  • 503  Richter JR, Forstrum LR, Kiistala UO, et al. Efficacy of the 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation and a proprietary 0.025% gel formulation in the topical control of facial acne. J Eur Acad Dermatol Venereol 1998;11:22733.Cross Ref linkPubmed link
  • 504  Bernstein JE, Lorincz AL. The effects of topical nicotinamide, tetracycline and dapsone and potassium iodide‐induced inflammation. J Invest Dermatol 1988;74:2578.
  • 505  Draelos ZD, Carter E, Maloney JM, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne. J Am Acad Dermatol 2007;56:439e110.
  • 506  Lucky AW, Maloney JM, Roberts J, et al. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long‐term (1 year) treatment. J Drugs Dermatol 2007;6:9817.Pubmed link
  • 507  Holland KT, Bojar RA. Antimicrobial effects of azelaic acid. J Dermatol Treat 1993;4(Suppl. 1):S811.Cross Ref link
  • 508  Leeming JP, Holland KT, Bojar RA. The in vitro antimicrobial effect of azelaic acid. Br J Dermatol 1986;115:5516.Cross Ref linkPubmed link
  • 509  Olsen TE. Therapy of acne. Med Clin North Am 1982;66:85177.Pubmed link
  • 510  Sykes NL, Webster GF. Acne: a review of optimum treatment. Drugs 1994;48:5970.Cross Ref linkPubmed link
  • 511  Stern RS. Acne therapy: medication use and sources of care in office‐based practice. Arch Dermatol 1996;132:77680.Cross Ref linkPubmed link
  • 512  Ross CM. The treatment of acne vulgaris with dapsone. Br J Dermatol 1961;73:36770.Cross Ref linkPubmed link
  • 513  Plewig G, Schill WB, Hofmann C. Orale Behandlung mit Tretinoin, andrologisone, trichologisone, opthalmologisone Befunde und Therapieergeb‐nisse bei Akne. Arch Dermatol Res 1979;265:3747.Cross Ref linkPubmed link
  • 514  Thiboutot D. Acne: an overview of clinical research findings. Dermatol Clin 1997;15:97109.Cross Ref linkPubmed link
  • 515  Anon. Is minocycline overused in acne? Drug Ther Bull 2006;44:604.Cross Ref linkPubmed link
  • 516  McManus P, Iheanacho I. Don't use minocycline as first line oral antibiotic in acne. BMJ 2007;334:154.Cross Ref linkPubmed link
  • 517  Knowles SR, Shear NH. Cutaneous drug reactions with systemic features. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy, 2nd edn. Philadelphia: Saunders Elsevier, 2007:97787.
  • 518  Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am J Gastroenterol 2000;95:5601,Pubmed link
  • 519  Ozolins M, Eady EA, Avery A, et al. A cost‐effectiveness rationale for the selection of antimicrobial therapy in acne: a randomized controlled trial. Br J Dermatol 2002;147:1318.Cross Ref linkPubmed link
  • 520  Fernandez‐Obregon AC. Azithromycin for the treatment of acne. Int J Dermatol 2000;39:4550.Cross Ref linkPubmed link
  • 521  Amin K, Riddle CC, Aires DJ, et al. Common and alternative oral therapies for acne vulgaris: a review. J Drugs Dermatol 2007;79:87380.
  • 522  Rothman KF, Pochi PE. Use of oral and topical agents for acne in pregnancy. J Am Acad Dermatol 1988;19:43142.Cross Ref linkPubmed link
  • 523  Carraso DA, Vander Straten M, Tyring SK. A review of antibiotics in dermatology. J Cutan Med Surg 2002;6:12850.Cross Ref linkPubmed link
  • 524  Lasson HE, Price AB. Pseudomembranous colitis: presence of clostridial toxin. Lancet 1977;ii:131214.
  • 525  Rafiei R, Yaghoobi R. Azithromycin versus tetracycline in the treatment of acne vulgaris. J Drugs Dermatol 2006;17:21721.
  • 526  Bhambri S, Del Rosso JQ, Desai A. Oral trimethoprim in the treatment of acne vulgaris. Cutis 2007;79:4304.Pubmed link
  • 527  Bottomley WW, Cunliffe WJ. Oral trimethoprim as a third‐line antibiotic in the management of acne vulgaris. Dermatology 1993;187:1936.Cross Ref linkPubmed link
  • 528  Cunliffe WJ, Aldana OL, Goulden V. Oral trimethoprim: a relatively safe and successful third‐line treatment for acne vulgaris. Br J Dermatol 1999;141:7578.Cross Ref linkPubmed link
  • 529  Gibson JR, Darley CR, Harvey SG, et al. Oral trimethoprim versus oxytetracycline in the treatment of inflammatory acne vulgaris. Br J Dermatol 1982;107:2214.Cross Ref linkPubmed link
  • 530  Remlinger KA. Hematologic toxicity of drug therapy. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy, 2nd edn. Philadelphia: Saunders Elsevier, 2007:9013.
  • 531  Archer J, Archer D. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. J Am Acad Dermatol 2002;46:91723.Cross Ref linkPubmed link
  • 532  Weaver K, Glasier A. Interaction between broad spectrum antibiotics and the combined oral contraceptive pill. A literature review. Contraception 1999;59:718.Cross Ref linkPubmed link
  • 533  Helms SE, Bredle DL, Zajic J, et al. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol 1997;36:70510.Cross Ref linkPubmed link
  • 534  London BM, Lookingbill DP. Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives [Letter]. Arch Dermatol 1994;130:3923.Cross Ref linkPubmed link
  • 535  Ross JI, Snelling AM, Carnegie E, et al. Antibiotic resistance: lessons from Europe. Br J Dermatol 2003;148:46778.Cross Ref linkPubmed link
  • 536  Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989;121:517.Cross Ref linkPubmed link
  • 537  Gardner KJ, Cunliffe WJ, Eady EA, et al. Variation in comedonal antibiotic concentrations following applications of topical tetracycline for acne vulgaris. Br J Dermatol 1994;131:64954.Cross Ref linkPubmed link
  • 538  Layton AM, Hughes BR, Hull SM, et al. Seborrhoea is an indication of poor response to systemic antibiotics. Clin Exp Dermatol 1992;17:1735.Cross Ref linkPubmed link
  • 539  Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for the treatment of acne. Cochrane Database Syst Rev 2012;(7):CD004425.
  • 540  Greenwood R, Brummitt L, Burne B, et al. Acne: double‐blind clinical and laboratory trial of tetracycline, oestrogen, cyproterone acetate and combined treatment. BMJ 1985;291:12315.Cross Ref linkPubmed link
  • 541  Vasilakis‐Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone contraceptives. Lancet 2001;358:14279.Cross Ref linkPubmed link
  • 542  Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 2004;22:41928.Cross Ref linkPubmed link
  • 543  Farquhar C, Lee O, Toomath R, et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2003;(4):CD000194.Pubmed link
  • 544  Greenwood R, Jones DH, Brummitt L. Comparison of isotretinoin and cyproterone acetate: a clinical and laboratory study. In: Cunliffe WJ, Miller AJ, eds. Retinoid Therapy. Lancaster: MTP Press, 1984:28792.Cross Ref link
  • 545  Larsen TH, Jemec GB. Acne: comparing hormonal approaches to antibiotics and isotretinoin. Exp Opin Pharmacother 2003;4:1097103.Cross Ref link
  • 546  Gollnick HP, Graupe K, Zaumseil RP. Cmparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001;11:53844.Pubmed link
  • 547  Oprica C, Emtesam L, Hagstromer L, et al. Clinical and microbiological comparisons of isotretinoin vs tetracycline in acne vulgaris. Acta Derm Venereol 2007;87:24654.Pubmed link
  • 548  Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vularis: a randomized comparative trial. Indian J Dermatol Venereol Leprol 2011;77:68894.Cross Ref linkPubmed link
  • 549  Lee JW, Yoo KH, Park KY, et al. Effectiveness of conventional, low dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study. Br J Dermatol 2011;164:136975.Cross Ref linkPubmed link
  • 550  Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 2006;20:7736.Cross Ref linkPubmed link
  • 551  European Directive for systemic isotretinoin prescription. European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products (CPMP) http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Isotretinoin_29/WC500010882.pdf (last accessed November 2015).
  • 552  Altman RS, Altman LJ, Altman JS. A proposed set of new guidelines for routine blood tests during isotretinoin therapy for acne vulgaris. Dermatology 2002;204:2325.Cross Ref linkPubmed link
  • 553  Amichai B, Grunwald MH. Isotretinoin in dermatology. J Dermatol Treat 2000;11:21940.Cross Ref link
  • 554  Zane LT, Leyden WA, Marqueling AL, et al. A population based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006;142:101622.Pubmed link
  • 555  Strauss JA, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicentre dose–response study. J Am Acad Dermatol 1994;10:4906.Cross Ref link
  • 556  Shalita AR. Acne revisited. Arch Dermatol 1994;130:3634.Cross Ref linkPubmed link
  • 557  Layton AM, Knaggs H, Taylor J, et al. Isotretinoin for acne vulgaris – 10 years later: a safe and successful treatment. Br J Dermatol 1993;129:2926.Cross Ref linkPubmed link
  • 558  Cunliffe WJ, van de Kerkhof P, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997;194;3517.Cross Ref linkPubmed link
  • 559  Gollnick H, Cunliffe WJ, Berson D, et al. Management of acne. A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003;49(1 Suppl.):S136.Cross Ref linkPubmed link
  • 560  Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify usage. BMJ 1993;306:5556.Cross Ref linkPubmed link
  • 561  Harms M, Masooye I, Radeff B. The relapses of cystic acne after isotretinoin treatment are age‐related: a long‐term follow up study. Dermatologica 1986;172:14853.Cross Ref linkPubmed link
  • 562  Goulden V, Clark SM, McGeown C, Cunliffe WJ. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997;137:1068.Cross Ref linkPubmed link
  • 563  Akman A, Durusoy C, Senturk M, et al. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res 2007;299:46773.Cross Ref linkPubmed link
  • 564  Goulden V, Clark SM, Cunliffe WJ. Treatment of adult acne with low dose intermittent isotretinoin. Br J Dermatol 1996;135(Suppl. 47):20.Cross Ref linkPubmed link
  • 565  Horne HL, Carmichael AJ. Juvenile nodulocystic acne responding to systemic isotretinoin. Br J Dermatol 1997;136:7967.Cross Ref linkPubmed link
  • 566  Miller IM, Echeverría B, Torrelo A, Jemec GB. Infantile acne treated with oral isotretinoin. Pediatr Dermatol 2013;3:51318.Cross Ref link
  • 567  Eichenfield LF, Krakowski AC, Piggot C, et al. Evidence based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013;131(Suppl. 3):S16386.Cross Ref linkPubmed link
  • 568  Clark SM, Cunliffe WJ. The use of isotretinoin in the treatment of acne in children. Br J Dermatol 1995;133(Suppl. 45):39.
  • 569  Parker TL, Roth JG, Esterly NB. Isotretinoin for acne in Apert syndrome. Pediatr Dermatol 1992;9:298300.Cross Ref linkPubmed link
  • 570  Williams REA, Doherty VR, Perkins W, et al. Staphylococcus aureus and intra‐nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 1992;126:3626.Cross Ref linkPubmed link
  • 571  Stern RS. When a uniquely effective drug is teratogenic: the case of isotretinoin. N Engl J Med 1989;320:10079.Cross Ref linkPubmed link
  • 572  Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: is there a causal link? J Am Acad Dermatol 2001;45:S16875.Cross Ref linkPubmed link
  • 573  Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;45:51519.Cross Ref linkPubmed link
  • 574  Jick SS, Kremmers HM, Vasilakis‐Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide and attempted suicide. Arch Dermatol 2000;136:1231.Cross Ref linkPubmed link
  • 575  Cohen J, Adams S, Patten S. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort. Can J Clin Pharmacol 2007;14:S22733.
  • 576  Azoulay L, Blais L, Koren G, et al. Isotretinoin and the risk of depression in patients with acne vulgaris: a case crossover study. J Clin Psychiatry 2008;69:52632.Cross Ref linkPubmed link
  • 577  Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995;55:1658.Pubmed link
  • 578  Clark SM, Cunliffe WJ. Acne flare and isotretinoin: incidence and treatment. Br J Dermatol 1995;133(Suppl. 45):26.
  • 579  Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthesia. Br J Dermatol 1991;125:2569.Cross Ref linkPubmed link
  • 580  Soria C, Allegue F, Galiana J, et al. Decreased isotretinoin efficacy during acute alcohol intake. Dermatologica 1991;182:203.Cross Ref linkPubmed link
  • 581  Tam M, Cooper A. The use of isotretinoin in a renal transplant patient with acne. Br J Dermatol 1988;116:463.Cross Ref link
  • 582  Kinaly C, Valkamo MH. Renal transplantation and isotretinoin. Acta Derm Venereol (Stockh) 1990;70:540.
  • 583  Verschoore M, Langner A, Wolska H, et al. Efficacy and safety of CD271 alcoholic gels in the topical treatment of acne vulgaris. Br J Dermatol 1991;124:36871.Cross Ref linkPubmed link
  • 584  Bernstein JE, Lorincz AL. The effects of topical nicotinamide, tetracycline and dapsone and potassium iodide‐induced inflammation. J Invest Dermatol 1988;74:2578.
  • 585  Griffiths CEM. Nicotinamide 4% gel for the treatment of inflammatory acne vulgaris. J Dermatol Treat 1995;6(Suppl. 1):810.
  • 586  Shalita AR, Smith JG, Parish LC, et al. A double‐blind comparison of topical nicotinamide with clindamycin gel for the treatment of inflammatory acne vulgaris. Int J Dermatol 1995;34:347.Cross Ref linkPubmed link
  • 587  Shalita AR. Treatment of mild and moderate acne vulgaris with salicyclic acid in an alcohol‐detergent vehicle. Cutis 1981;28:5568.Pubmed link
  • 588  Eady EA, Burke BM, Pulling K, et al. The benefit of 2% salicylic acid lotion in acne: a placebo controlled study. J Dermatol Treat 1996;7:936.Cross Ref link
  • 589  Mills OH, Kligman AM. Is sulphur helpful or harmful in acne vulgaris? Br J Dermatol 1972;86:6207.Cross Ref linkPubmed link
  • 590  Strauss JS, Goldman PH, Nacht S, et al. A re‐examination of the potential comedogenicity of sulfur. Arch Dermatol 1978;114:13402.Cross Ref linkPubmed link
  • 591  Mills OH, Kligman AM. Assay of comedolytic activity in acne patients. Acta Derm Venereol (Stockh) 1983;63:6871.
  • 592  MacDonald‐Hull SM, Cunliffe WJ. The use of a corticosteroid cream for immediate reduction in the clinical signs of acne vulgaris. Acta Derm Venereol (Stockh) 1989;69:4523.
  • 593  Higaki S, Nakamura M, Morohashi M, et al. Anti‐lipase activity of Kamkpo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes. J Dermatol 1996;23:31014.Cross Ref linkPubmed link
  • 594  Ernst E, Huntley A. Tea tree oil: a systematic review of randomised trials. Forsch Komplementarmed Klass Naturheikd 2000;7:1720.Cross Ref link
  • 595  Magin PJ, Adams J, Pond CD, et al. Topical and oral CAM in acne: a review of the empirical evidence and consideration of its context. Complement Ther Med 2006;14:6276.Cross Ref linkPubmed link
  • 596  Bagherani N, Smoller B. Role of tea tree oil in treatment of acne. Dermatol Ther 2015 doi: 10.1111/dth.12235.
  • 597  Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthesia. Br J Dermatol 1991;125:2569.Cross Ref linkPubmed link
  • 598  Yip J, Peppall L, Gawkrodger DJ, Cunliffe WJ. Light cautery and EMLA® in the treatment of chloracne lesions. Br J Dermatol 1993;128:31316.Cross Ref linkPubmed link
  • 599  Bottomley WW, Yip J, Knaggs H, Cunliffe WJ. Treatment of closed comedones: comparisons of fulguration with topical tretinoin and electrocautery with fulguration. Dermatology 1993;186:2537.Cross Ref linkPubmed link
  • 600  Elman M, Slatkine M, Harth Y. The effective treatment of acne vulgaris by a high‐intensity, narrow band 405–420 nm light source. J Cosmet Laser Ther 2003;5:11117.Cross Ref linkPubmed link
  • 601  Tzung TY, Wu KH, Huang ML. Blue light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed 2004;20:2669.Cross Ref linkPubmed link
  • 602  Zhong JQ, Xian DH, Chen DY. The clinical efficacy of narrowband blue light in the treatment of acne vulgaris. J Clin Dermatol 2007;36:11516.
  • 603  Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA‐photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000;115:18392.Cross Ref linkPubmed link
  • 604  Zeina B, Greenman J, Corry D, et al. Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes. Br J Dermatol 2002;146:56873.Cross Ref linkPubmed link
  • 605  Hædersdal M, Togsverd‐Bo K, Wulf HC. Evidence‐based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol 2008;22:26778.Cross Ref linkPubmed link
  • 606  Orringer JS, Kang S, Maier L, et al. A randomized, controlled, split‐face clinical trial of 1320–nm Nd:YAG laser therapy in the treatment of acne vulgaris. J Am Acad Dermatol 2007;56:4328.Cross Ref linkPubmed link
  • 607  Chang SE, Ahn SJ, Rhee DY, et al. Treatment of facial acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530‐ to 750‐nm filter. Dermatol Surg 2007;33:6769.Pubmed link
  • 608  Yeung CK, Shek SY, Bjerring P, et al. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin. Lasers Surg Med 2007;39:16.Cross Ref linkPubmed link
  • 609  Seaton E, Charikida A, Mouser PE, et al. Pulsed dye laser treatment for inflammatory acne vulgaris: a randomised controlled trial. Lancet 2003;362:134752.Cross Ref linkPubmed link
  • 610  Alexiades‐Armenakas M. Long‐pulsed dye laser‐mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory or cystic acne. J Drugs Dermatol 2006;5:4555.Pubmed link
  • 611  Yeung CK, Shek SY, Bjerring P, et al. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin. Lasers Surg Med 2007;39:16.Cross Ref linkPubmed link
  • 612  Furukawa F, Yamamoto Y. Recent advances in chemical peeling in Japan. J Dermatol 2006;33:65561.Cross Ref linkPubmed link
  • 613  Dreno B, Fischer TC, Perosino E, et al. Expert opinion: efficacy of superficial chemical peels in active acne management: what can we learn from the literature today? Evidence based recommendations. J Eur Acad Dermatol Venereol 2011;25:695704.Cross Ref linkPubmed link
  • 614  Burns RE, Colville JM. Acne conglobata with septicaemia. Arch Dermatol 1959;79:3613.Cross Ref link
  • 615  Plewig G, Kligman AM. Acne: Morphogenesis and Treatment. Berlin: Springer‐Verlag, 1975:196.
  • 616  Karoven SL. Acne fulminans: report of clinical findings and treatment of twenty‐four patients. J Am Acad Dermatol 1993;28:5729.Cross Ref linkPubmed link
  • 617  Thompson KF, Cunliffe WJ. Acne fulminans ‘sine fulminans’. Clin Exp Dermatol 2000;25:299301.Cross Ref linkPubmed link
  • 618  Zaba R, Shwatrz RA, Jarmuda S, et al. Acne fulminans: explosive systemic form of acne. J Eur Acad Dermatol Venereol 2011;25:5017.Cross Ref linkPubmed link
  • 619  Neely GM, Hein MS. Acne fulminans: a case report. South Dakota Med 2006;59:3879.
  • 620  Tamaki C, Miyatake J, Yamagat T, et al. Case of acne fulminans associated with hemophagocytosis. Nippon Naika Zasshi 2004;93:16323.
  • 621  Kurokawa S, Tokura Y, Nham NS, et al. Acne fulminans coexisting with pyoderma gangrenosum‐like eruptions and posterior scleritis. J Dermatol 1996;23:3741.Cross Ref linkPubmed link
  • 622  McAuley D, Miller RA. Acne fulminans associated with inflammatory bowel disease: report of a case. Arch Dermatol 1985;121:913.Cross Ref linkPubmed link
  • 623  Wakabayashi M, Fujimoto N, Uenishi T, Danno K, Tanaka T. A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory bowel disease. Dermatology 2011;222:2315.Cross Ref linkPubmed link
  • 624  Kurokawa S, Tokura Y, Nham NX, et al. Acne fulminans coexisting with pyoderma gangrenosum‐like eruptions and posterior scleritis. J Dermatol 1996;23:3741.Cross Ref linkPubmed link
  • 625  Tallon B, Corkill M. Peculiarities of PAPA syndrome. Rheumatology 2006;45:11403.Cross Ref linkPubmed link
  • 626  Fyrand O, Fiskadaal HJ, Trygstad O. Acne in pubertal boys undergoing treatment with androgens. Acta Derm Venereol (Stockh) 1992;72:1489.
  • 627  Traupe H, von Muhendahl KE, Bramswig J, et al. Acne of the fulminans type following testosterone therapy in three excessively tall boys. Arch Dermatol 1988;124:41417.Cross Ref linkPubmed link
  • 628  Hartmann AA, Burg G. Acne fulminans bei Klinefelter‐Syndrom unter Testosteron. Monatsschr Kinderheilkd 1989;137:4667.Pubmed link
  • 629  McFadden N. Testosterone‐induced acne fulminans in a patient treated for tall stature. J Dermatol Treat 1989;1:334.Cross Ref link
  • 630  Wollina U, Hansel G, Koch A, et al. Case reports: acne fulminans in Marfan's syndrome. J Drugs Dermatol 2005;4:5015.Pubmed link
  • 631  Placzek M, Degitz K, Schmidt H, Plewig G. Acne fulminans in late‐onset congenital adrenal hyperplasia. Lancet 1999;354:73940.Cross Ref linkPubmed link
  • 632  Heydenreich G. Testosterone and anabolic steroids and acne fulminans. Arch Dermatol 1989;125:5712.Cross Ref linkPubmed link
  • 633  Krauss SL, Emmert S, Schon M, et al. The dark side of beauty: acne fulminans induced by anabolic steroids in a male body builder. Arch Dermatol 2012;148:121011.Cross Ref linkPubmed link
  • 634  Melnik B, Jansen T, Grabbe S. Abuse of anabolic‐androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges 2007;5:11017.Cross Ref linkPubmed link
  • 635  Scott MJ III, Scott AM. Effects of anabolic‐androgenic steroids on the pilosebaceous unit. Cutis 1992;50:11316.Pubmed link
  • 636  Kellet JK, Beck MH, Chalmers RJG. Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin. BMJ 1985;290:820.Cross Ref link
  • 637  Karvonen SL, Rasanen L, Cunliffe WJ, et al. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans. Dermatology 1994;189:3449.Cross Ref linkPubmed link
  • 638  Perkins W, Crocket KV, Hodgkins MB, et al. The effect of 13‐cis‐retinoic acid on the metabolic burst of peripheral blood neutrophils from patients with acne. Br J Dermatol 1991;124:42932.Cross Ref linkPubmed link
  • 639  Darley CR, Currey HL, Baker H. Acne fulminans with arthritis in identical twins treated with isotretinoin. J R Soc Med 1984;77:32830,Pubmed link
  • 640  Gonzales T, Gantes M, Bustabad S, et al. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol 1985;12:38990.
  • 641  Wong SS, Pitchard MH, Holt PJA. Familial acne fulminans. Clin Exp Dermatol 1992;17:3513.Cross Ref linkPubmed link
  • 642  Homna M, Murakami M, Iinuma S, et al. Acne fulminans following a measles infection. J Dermatol 2009;36:4713.Cross Ref linkPubmed link
  • 643  Jansen T, Romiti R, Woitalla S, et al. Eruptive acne vulgaris with infectious mononucleosis. Br J Dermatol 2000;142:8378.Cross Ref linkPubmed link
  • 644  Mehrany K, Kist JM, Weenig RH, et al. Acne fulminans. Int J Dermatol 2005;44:1323.Cross Ref linkPubmed link
  • 645  van Schaardenburg D, Lavrijsen S, Vermeer B‐J. Acne fulminans associated with painful splenomegaly. Arch Dermatol 1989;125:1323.Cross Ref linkPubmed link
  • 646  Williamson DM, Cunliffe WJ, Gatecliff M, et al. Acute ulcerative acne conglobata (acne fulminans) with erythema nodosum. Clin Exp Dermatol 1977;2:3514.Cross Ref linkPubmed link
  • 647  Lane JM, Leyden JJ, Spiegel RJ. Acne arthralgia. J Bone Joint Surg 1976;58:6735.Pubmed link
  • 648  Siegel D, Strosberg JM, Wiese F, et al. Acne fulminans with osteolytic bone lesions responsive to dapsone. J Rheumatol 1982;92:3446.
  • 649  Kellet JK, Beck MH, Chalmers RJG. Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin. BMJ 1985;290:820.Cross Ref link
  • 650  Laasonen LS, Karvonen SL, Reunala TL. Bone disease in adolescents with acne fulminans and severe cystic acne: radiologic and scintigraphic findings. Am J Roentgenol 1994;162:11615.Cross Ref link
  • 651  Siegel D, Strosberg JM, Wiese F, et al. Acne fulminans with osteolytic bone lesions responsive to dapsone. J Rheumatol 1982;92:3446.
  • 652  Chua SL, Ravenscroft J. Acne fulminans: part of a spectrum of SAPHO. Br J Dermatol 2007;156:1408.Cross Ref link
  • 653  Chua SL, Angus JE, Ravenscroft J, et al. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome and acne fulminans: are they part of the same disease spectrum? Clin Exp Dermatol 2009;34:2413.Cross Ref link
  • 654  Nault P, Lassonde M, St‐Antoine P. Acne fulminans with osteolytic lesions. Arch Dermatol 1985;121:6624.Cross Ref linkPubmed link
  • 655  Knuchel M, Luderschmidt CR. Knochennikrose bei acne conglobata. Z Hautkr 1986;61:10928.Pubmed link
  • 656  Strom S, Thyresson N, Bostrom H. Acute febrile ulcerative conglobate acne with leukemoid reaction. Acta Derm Venereol (Stockh) 1973;53:30612.
  • 657  Jemec GBE, Rasmussen I. Bone lesions of acne fulminans: case report and review of the literature. J Am Acad Dermatol 1989;20:3537.Cross Ref linkPubmed link
  • 658  Knitzer RH, Needleman BW. Musculoskeletal syndromes associated with acne. Semin Arthritis Rheum 1991;20:24755.Cross Ref linkPubmed link
  • 659  Choi EH, Bang D. Acne fulminans and 13‐cis‐retinoic acid. J Dermatol 1992;19:37883.Cross Ref linkPubmed link
  • 660  Karvonen SL, Vaalasti A, Kautiainen H, Reunala T. Systemic corticosteroid and isotretinoin treatment in cystic acne. Acta Derm Venereol (Stockh) 1993;73:4525.
  • 661  Jansen T, Plewig G. Acne fulminans. Int J Dermatol 1998;37:2547.Cross Ref linkPubmed link
  • 662  Tan BB, Lear JT, Smith AG. Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone. Clin Exp Dermatol 1997;22:267.Cross Ref linkPubmed link
  • 663  Prendiville I, Cream JJ. Clofazimine responsive acne vulgaris. Br J Dermatol 1983;109(Suppl. 24):901.Cross Ref link
  • 664  Allison MA, Dunn CL, Pearson CA. Acne fulminans treated with isotretinoin and pulsed corticosteroid. Pediatr Dermatol 1997;4:3942.Cross Ref link
  • 665  Woolfson H, Road H. Acne fulminans with circulating immune complexes and leukemoid reaction treated with steroids and azathioprine. Clin Exp Dermatol 1987;12:4636.Cross Ref linkPubmed link
  • 666  Tago O, Nagai Y, Matsushima Y, et al. A case of acne fulminans treated with cyclosporine A and prednisolone. Acta Derm Venereol (Stockh) 2011;91:3378.Cross Ref link
  • 667  Giaevedoni P, Mascaro‐Galy J, Aguilera P, et al. Acne fulminans successfully treated with cyclosporine and isotretinoin. J Am Acad Dermatol 2014;70:e389.Cross Ref linkPubmed link
  • 668  Seukeran DC, Cunliffe WJ. The treatment of acne fulminans: a review of 25 cases. Br J Dermatol 1999;141:3079.Cross Ref linkPubmed link
  • 669  Hartmann RR, Plewig G. Acne fulminans: tratamento de 11 pacientes com o ácido 13‐cis‐retinóico. An Bras Dermatol 1983;58:310.
  • 670  Von Den Driesch P, Schell H, Haneke E. Fulminant acne: therapy with 13‐cis‐retinoic acid and indomethacin. Z Hautkr 1986;61:114551.Pubmed link
  • 671  Lages R, Bona SH, Silva FV, Gomes AK, Campelo V. Acne fulminans successfully treated with prednisone and dapsone. An Bras Dermatol 2012;87:61214.Cross Ref linkPubmed link
  • 672  Patterson WM, Stibich AS, Dobke M, Schwartz RA. Mutilating facial acne conglobata. Cutis 2000;66:13940.Pubmed link
  • 673  Pagano A, Feldman MJ. Management of chronic gluteal follicular occlusive disease. Eplasty 2013;13:ic50.Pubmed link
  • 674  Chicarilli N. Follicular occlusion triad: hidradenitis suppurativa, acne conglobata and dissecting cellulites of the scalp. Ann Plast Surg 1987;18:2307.Cross Ref linkPubmed link
  • 675  Ehrenfeld M, Samra Y, Kaplinsky N, et al. Acne conglobata and arthritis: report of a case and review of the literature. Clin Exp Rheumatol 1986;5:4079.Cross Ref link
  • 676  Vasey FB, Fenske NA, Clement GB, et al. Immunological studies of the arthritis of acne conglobate and hidradenitis suppuritiva. Clin Exp Rheumatol 1984;2:30911.Pubmed link
  • 677  Ziff M, Maliakkal J. Acne conglobate and arthritis. Ann Intern Med 1983;98:417.Cross Ref linkPubmed link
  • 678  Lim DT, James NM, Hassan S, et al. Spondyloarthritis associated with acne congolobata, hidradentitis suppuritiva and dissecting cellulitis of the scalp: a review with illustrative cases. Curr Rheumatol Rep 2013;15:346.Cross Ref linkPubmed link
  • 679  Velez A, Alcala J, Fernadez‐Roldan JC. Pyoderma gangrenosum associated with acne conglobate. Clin Exp Dermatol 1995;20:4968.Cross Ref linkPubmed link
  • 680  Benhamou CL, Enjolras O, Delrieu F, et al. The SAPHO syndrome. Semin Arthritis Rheum 2012;42:2546.Cross Ref linkPubmed link
  • 681  Braun‐Falco M, Kovverystyy O, Lohse P, et al. Pyoderma gangrenosum, acne and suppurative hidradrenitis suppuritiva (PASH): a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012;66:40915.Cross Ref linkPubmed link
  • 682  Bruzzese V. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis and axial sponyloarthritis: efficacy of anti‐tumor necrosis factor a therapy. J Clin Rheumatol 2012;18:41315.Cross Ref linkPubmed link
  • 683  Melnik B, Jansen T, Grabbe S. Abuse of anabolic‐androgenic steroids and body building acne: an underestimated health problem. J Dtsch Dermatol Ges 2007;5:11017.Cross Ref linkPubmed link
  • 684  Ena P, Zanetti S, Sechi LA. Mycobacertium chelonae I infection mimicking acne conglobate in an immunocompetent host. Clin Exp Dermatol 2004;29:4235.Cross Ref linkPubmed link
  • 685  Yeon HB, Lindon NM, Seidman JG, et al. Pyogenic arthritis, pyoderma gangrenosum and acne syndrome maps to chromosome 15q. Am J Hum Genet 2000;66:14438.Cross Ref linkPubmed link
  • 686  Wollenberg A, Wolff H, Jansen T, et al. Acne conglobate and Klinefelter's syndrome. Br J Dermatol 1997;136:4213.Cross Ref linkPubmed link
  • 687  Schackert K, Scholz S, Steinbauer‐Rosenthal I, et al. HLA‐A antigens in acne conglobate: a negative study. Arch Dermatol 1974;110:468.Cross Ref linkPubmed link
  • 688  Whipp MJ, Harrington CI, Dundas S. Fatal squamous cell carcinoma associated with acne conglobata in a father and daughter. Br J Dermatol 1987;117:38992.Cross Ref linkPubmed link
  • 689  Birnkrant MJ, Papdopoulos AJ, Scwartz RA, et al. Pyoderma gangrenosum, acne conglobate and IgA gammopathy. Int J Dermatol 2003;42:21316.Cross Ref linkPubmed link
  • 690  Perez‐Villa F, Campistol JM, Ferrando J, et al. Renal amyloidosis secondary to acne conglabata. Int J Dermatol 1989;28:1323.Cross Ref linkPubmed link
  • 691  Leyden JJ, Mills OH, Kligman AM. Cryoprobe treatment of acne conglabata. Br J Dermatol 1974;90:33541.Cross Ref linkPubmed link
  • 692  Weinrack L, Peled I, Hacham‐Zadah S, et al. Surgical treatment of severe acne conglobate. J Dermatol Surg Oncol 1981;7:4924.Cross Ref linkPubmed link
  • 693  Haregawa T. Acne conglobate successfully treated by fractional laser after CO2 laser abrasion of cysts combined with topical tretinoin. J Dermatol 2009;36:11819.Cross Ref linkPubmed link
  • 694  Myers JN, Mason AR, Gillespie LK, et al. Treatment of acne conglobate with modern external beam radiation. J Am Acad Dermatol 2010;62:8613.Cross Ref linkPubmed link
  • 695  Jeong SJ, Lee CW. Acne conglobata: treatment with isotretinoin, colchicine and cyclosporin as compared with surgical intervention. Clin Exp Dermatol 1996;21:4623.Cross Ref linkPubmed link
  • 696  Schwartz RA. Acne conglobata treatment and management http://emedicine.medscape.com/article/1072716‐treatment (last accessed November 2015).
  • 697  Bolz S, Jappe U, Hartschuh W. Successful treatment of peri‐folliculitis capitis abscendens et suggodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges 2008;6:447.Cross Ref linkPubmed link
  • 698  Shirakam M, Uramoto K, Harad FA, et al. Treatment of acne conglobata with infiliximab. J Am Acad Dermatol 2006;55:3446.Cross Ref linkPubmed link
  • 699  Schuttelaar ML, Leeman FW. Sustained remission of nodular inflammatory acne after treatment with infliximab. Clin Exp Dermatol 2011;36:6701.Cross Ref linkPubmed link
  • 700  Campione E, Mazzotta AM, Bianchi L, et al. Severe acne successfully treated with etanercept. Acta Derm Venereol (Stockh) 2006;86:2567.Cross Ref link
  • 701  Su YS, Chang CH. SAPHO syndrome associated with acne conglobata successfully treated with etancercept. J Formos Med Assoc 2015;114:5624.Cross Ref linkPubmed link
  • 702  Sand F. Adalimumab for the treatment of refractory acne conglobata. JAMA Dermatol 2013;149:1307.Cross Ref link
  • 703  Yang GL, Zhao M, Wang JM, et al. Short‐term clinical effects of photodynamic therapy with topical 5‐aminolevulinic acid for facial acne conglobate: an open prospective, parallel arm trial. Photodermatol Photoimmunol Photomed 2013;29:2338.Cross Ref linkPubmed link
  • 704  Jeong SJ, Lee CW. Acne conglobata: treatment with isotretinoin, colchicine and cyclosporin as compared with surgical intervention. Clin Exp Dermatol 1996;21:4623.Cross Ref linkPubmed link
  • 705  Schwartz RA. Acne conglobata treatment and management, 2012 http://emedicine.medscape.com/article/1072716‐treatment (last accessed November 2015).
  • 706  Haregawa T, Matsukura T, Suga Y. One case of acne conglobata treated by the CO2 laser combined with tretinoin. J Dermatol 2007;34:5835.Cross Ref linkPubmed link
  • 707  Bolz S, Jappe U, Hartschuh W. Successful treatment of perifolliculitis capitis abscendens et suggodiens with combined isotretinoin and dapsone. J Dtsch Dermatol Ges 2008;6:447.Cross Ref linkPubmed link
  • 708  Yung‐Shun Su, Chung‐Hsing Chang, SAPHO syndrome associated with acne conglobate successfully treated with etancercept. J Formosan Med Soc 2013;xx:13.
  • 709  Jansen T, Linder A, Plewig G. Draining sinus in acne and rosacea. A clinical, histopathologic and experimental study. Hautarzt 1995;46:41720.Cross Ref linkPubmed link
  • 710  Herxheimer K. Über Chloracne. Münch Med Wochenschr 1899;46:278.
  • 711  Zouboulis CC. Acne venenata und acne cosmetica. In: Braun‐Falco O, Gloor M, Korting HC, eds. Nutzen und Risiko von Kosmetika. Berlin: Springer‐Verlag, 2000:11623.Cross Ref link
  • 712  Ju Q, Yiang K, Zouboulis CC, Ring J, Chen W. Chloracne: from clinic to research. Dermatol Sinica 2012;30:26.Cross Ref link
  • 713  Ju Q, Zouboulis CC, Xia L. Environmental pollution and acne‐chloracne. Dermatoendocrinology 2009;1:1258.Cross Ref link
  • 714  McDonnell JK, Taylor JS. Occupational and environmental acne. In: Kanerva L, Elsner P, Wahlberg JE, Maibach HI, eds. Handbook of Occupational Dermatology. Berlin: Springer‐Verlag, 2000:22533.Cross Ref link
  • 715  Ju Q, Zouboulis CC. Effects of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin on the skin. Biosafety 2013;2:3.
  • 716  Kimmig J, Schulz KH. Berufliche Akne (sog. Chlorakne) durch chlorierte aromatische zyklische Äther. Dermatologica 1957;115:5406.Cross Ref linkPubmed link
  • 717  Zober A, Messerer P, Huber P. Thirty‐four‐year mortality follow‐up of BASF employees exposed to 2,3,7,8‐TCDD after the 1953 accident. Int Arch Occup Environ Health 1990;62:13957.Cross Ref linkPubmed link
  • 718  Dalderup LM, Zellenrath D. Dioxin exposure: 20 year follow‐up. Lancet 1983;ii:11345.Cross Ref linkPubmed link
  • 719  Pesatori AC, Consonni D, Bachetti S, et al. Short‐ and long‐term morbidity and mortality in the population exposed to dioxin after the ‘Seveso accident’. Ind Health 2003;41:12738.Cross Ref linkPubmed link
  • 720  Yoshimura T. Yusho in Japan. Ind Health 2003;41:13948.Cross Ref linkPubmed link
  • 721   YC, Wu YC. Clinical findings and immunological abnormalities in Yu‐Cheng patients. Environ Health Perspect 1985;59:1729.Cross Ref linkPubmed link
  • 722  Institute of Medicine (US) Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides. Veterans and Agent Orange: Update 2000 (Third Biennial Update). Washington, DC: National Academies Press, 2001.
  • 723  Saurat JH, Kaya G, Saxer‐Sekulic N, et al. The cutaneous lesions of dioxin exposure: lessons from the poisoning of Victor Yushchenko. Toxicol Sci 2012;125:31017.Cross Ref linkPubmed link
  • 724  Geusau A, Abraham K, Geissler K, Sator MO, Stingl G, Tschachler E. Severe 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin (TCDD) intoxication: clinical and laboratory effects. Environ Health Perspect 2001;109:8659.Cross Ref linkPubmed link
  • 725  Geusau A, Tschachler E, Meixner M, et al. Olestra increases faecal excretion of 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin. Lancet 1999;354:12667.Cross Ref linkPubmed link
  • 726  Kim W, Mancinic AJ. Acne in childhood: an update. Pediatr Ann 2013;42:41827.Cross Ref linkPubmed link
  • 727  Bernier V, Weill FX, Hirigoyen V, et al. Skin colonization with Malassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 2002;138:21518.Cross Ref linkPubmed link
  • 728  Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology 2003;206:248.Cross Ref linkPubmed link
  • 729  Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol 1999;38:12830.Cross Ref linkPubmed link
  • 730  Yonkosky DM, Pochi PE. Acne vulgaris in childhood: pathogenesis and management. Dermatol Clin 1986;4:12736.Cross Ref linkPubmed link
  • 731  Mancini AJ, Baldwin HE, Eichenfield LF, et al. Acne life cycle: the spectrum of pediatric disease. Semin Cutan Surg 2011;30(3 Suppl.):S25.Cross Ref link
  • 732  Mancini AJ, Baldwin HE, Eichenfield LF. Acne life cycle: the spectrum of pediatric disease. Semin Cutan Med Surg 2011;30(3 Suppl.):S2S5.Cross Ref linkPubmed link
  • 733  Antoniou C, Dessinioti C, Stratigos AJ, et al. Clinical and therapeutic approach to childhood acne: an update. Pediatr Dermatol 2009;26:37380.Cross Ref linkPubmed link
  • 734  Hello M, Perry S, Leaute‐Labreze C, et al. Infantile acne: a retrospective study of 16 cases. Pediatr Dermatol 2008;25:4348.Cross Ref linkPubmed link
  • 735  Biro FM, Huang B, Crawford PB, et al. Pubertal correlates in black and white girls. J Pediatr 2006;148:23440.Cross Ref linkPubmed link
  • 736  Benedetta C, Beretta‐Piccoli MJ, Sauvain IM, et al. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature. Eur J Pediatr 2000;159:595601.
  • 737  Brazzelli V, Larizza D, Muzio F, et al. Low frequency of acne vulgaris in adolescent girls and women with Turner's syndrome: a clinical, genetic and hormonal study of 65 patients. Br J Dermatol 2008;159:120911.Pubmed link
  • 738  Lucky AW. A review of infantile and paediatric acne. Dermatology 1998;196:957.Cross Ref linkPubmed link
  • 739  Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990;15:3767.Cross Ref linkPubmed link
  • 740  Stewart ME, Downing DT, Cook JS, et al. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992;128:13458.Cross Ref linkPubmed link
  • 741  Lucky A, Biro FM, Simbart LA, et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five‐year longitudinal study. J Pediatr 1997:130:309.Cross Ref linkPubmed link
  • 742  Mann MW, Ellis SS, Mallory SB. Infantile acne as the initial sign of an adrenocortical tumor. J Am Acad Dermatol 2007;56(2 Suppl.):S1518.Cross Ref linkPubmed link
  • 743  Schroeder B. Early diagnosis, presenting complaints and management of hyperandrogenism in adolescents. Curr Womens Health Rep 2001;1:12430.Pubmed link
  • 744  Degitz K, Placzek M, Arnold B, et al. Congenital adrenal hyperplasia and acne in male patients. Br J Dermatol 2003;146:12636.Cross Ref link
  • 745  Mourelatas K, Eady EA, Cunliffe WJ, et al. Temporal changes in sebum excretion and propionibacteria: colonization in preadolescent children with and without acne. Br J Dermatol 2007;156:2231.Cross Ref linkPubmed link
  • 746  Rapelanoro R, Mortureux P, Couprie B, et al. Neonatal Malasezzia fufur pustulosis. Arch Dermatol 1996:132:1903.Cross Ref linkPubmed link
  • 747  Ayhan M, Sancak B, Karaduman A, et al. Colonisation of neonatal skin by Malasezzia species: relationship with neonatal cephalic pustulosis. J Am Acad Dermatol 2007;57:101218.Cross Ref linkPubmed link
  • 748  Stankler L, Campbell AGM. Neonatal acne vulgaris: a possible feature of the fetal hydantoin syndrome. Br J Dermatol 1980;103:4535.Cross Ref linkPubmed link
  • 749  Nanda S, Reddy BSN, Ramji S, et al. Analytical study of pustular eruptions in neonates. Pediatr Dermatol 2002;19:20115.
  • 750  Barnes CJ, Eichenfield LF, Lee J, et al. A practical approach for the use of isotretinoin for infantile acne. Pediatr Dermatol 2005;22:1669.Cross Ref linkPubmed link
  • 751  Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol 2001;145:4636.Cross Ref linkPubmed link
  • 752  Cantatore‐Francis JL, Glick SA. Childhood acne: evaluation and management. Dermatol Ther 2006;19:2029.Cross Ref linkPubmed link
  • 753  Saenger P, Dimartino‐Nardi J. Premature adrenarche. J Endocrinol Invest 2001;24:72433.Cross Ref linkPubmed link
  • 754  Idkowiak J, Lavery GG, Dhir V, et al. Premature adrenarche: novel lessons from early onset androgen excess. Eur J Endocrinol 2011;165:189201.Cross Ref linkPubmed link
  • 755  Aracting S, Cadranel S, Reygagne P, et al. Pustulose neonatale induite par Malasezzia furfur. Ann Dermatol Vénéréol 1991;118:8568.
  • 756  Bergman JN, Eichenfield LF. Neonatal acne and cephalic pustulosis: is Malassezia the whole story? Arch Dermatol 2002;138:2557.Cross Ref linkPubmed link
  • 757  Niamba P, Weill FX, Sarlangue J, et al. Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia synpodialis? Arch Dermatol 1998;134:9958.Cross Ref linkPubmed link
  • 758  Bree A, Siegfried E. Acne vulgaris in preadolescent children: recommendations for evaluation. Pediatr Dermatol 2014;31:2732.Cross Ref linkPubmed link
  • 759  Hellier FF. Acneiform eruptions in infancy. Br J Dermatol 1954;66:259.Cross Ref linkPubmed link
  • 760  Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990;15:3767.Cross Ref linkPubmed link
  • 761  Dupont C. A study of juvenile acne [Letter]. Clin Exp Dermatol 1989;14:1756.Cross Ref linkPubmed link
  • 762  Sarazin F, Dompmartin A, Nivot S, et al. Treatment of an infantile acne with oral isotretinoin. Eur J Dermatol 2004;14:712.Pubmed link
  • 763  Torrelo A, Pastor A, Zambrano A. Severe acne infantum successfully treated with isotretinoin. Pediatr Dermatol 2005;22:3579.Cross Ref linkPubmed link
  • 764  Brechler AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003;49:17182Cross Ref linkPubmed link
  • 765  Burkett JM, Storrs FJ. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol 1987;123:4323.Cross Ref linkPubmed link
  • 766  Arbegast KD, Braddock SW, Lamberty FL, et al. Treatment of infantile cystic acne with oral isotretinoin. Pediatr Dermatol 1991;8:1668.Cross Ref linkPubmed link
  • 767  Horne HL, Carmichael AJ. Juvenile nodulocystic acne responding to systemic isotretinoin. Br J Dermatol 1997:136:7967.Cross Ref linkPubmed link
  • 768  Leaute‐Labreze C, Gautier C, Labbe L, et al. Infantile acne and isotretinoin. Ann Dermatol Venereol 1998:125:1324.Pubmed link
  • 769  Mengesha YM, Hansen RC. Toddler‐age nodulocystic acne. J Pediatr 1999;134:6448.Cross Ref linkPubmed link
  • 770  Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol 2001;145:4636.Cross Ref linkPubmed link
  • 771  Sarazin F, Dompmartin A, Nivot S, et al. Treatment of an infantile acne with oral isotretinoin. Eur J Dermatol 2004;14:712.Pubmed link
  • 772  Barnes CJ, Eichenfield LF, Lee J, et al. A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol 2005;22:1669.Cross Ref linkPubmed link
  • 773  Hello M, Prey S, Leaute‐Labreze C, et al. Infantile acne: a retrospective study of 16 cases. Pediatr Dermatol 2008;25:4348.Cross Ref linkPubmed link
  • 774  Miller IM et al. Infantile acne treated with oral isotretinoin. Pediatr Dermatol 2013;3:51318.Cross Ref link
  • 775  Holm EA, Jemec GB. Acne neonatorum/acne infantum. Ugeskr Laeger 2000;162:68567.
  • 776  Torello A, Pastor MA, Zambrano A. Severe acne infantum successfully treated with isotretinoin. Pediatr Dermatol 2005;22:3579.
  • 777  Lee SE, Kim J‐M, Jeong SK, Choi EH, Zouboulis CC, Lee SH. Expression of protease‐activated receptor‐2 in SZ95 sebocytes and its role in sebaceous lipogenesis, inflammation, and innate immunity. J Invest Dermatol 2015;135:2338.Cross Ref linkPubmed link
  • 778  Huang YC, Yang CH, Li TT, Zouboulis CC, Hsu HC. Cell‐free extracts of Propionibacterium acnes stimulate cytokine production through activation of p38 MAPK and Toll‐like receptor in SZ95 sebocytes. Life Sci 2015;139:12331.Cross Ref linkPubmed link